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Abstract 
Aims. Fatigue is a severe problem for patients with fibromyalgia (FM) and 
chronic widespread pain (CWP). The general aims of the thesis were to 
describe the fatigue experienced by patients with FM and CWP, explore the 
usefulness of the Multidimensional Fatigue Inventory (MFI-20) in women 
with FM and investigate the effects of different types of physiotherapy on 
fatigue and other health related aspects in patients with FM and CWP.  
Methods. The patients in the thesis were mainly recruited from primary 
health care. Two methodological studies were performed to investigate 
psychometric properties and usefulness of the Multidimensional fatigue 
inventory (MFI-20). Ratings of fatigue were also compared between different 
populations. Two randomized-controlled studies were conducted to evaluate 
effects of physiotherapy in patients with FM and CWP.  
Results. I. The study included 166 women and 44 men with FM and CWP 
(the analyses in men were additional in the thesis). All five subscales of the 
MFI-20 showed fair to moderate (women) and moderate to good (men) 
associations with the one-dimensional subscale of fatigue included in the 
Fibromyalgia Impact Questionnaire (FIQ), indicating sufficient convergent 
validity. In analyses of 36 women and 26 men with FM and CWP, the MFI-
20 was found to possess acceptable test-retest reliability and internal 
consistency. 
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(the analyses in men were additional in the thesis). All five subscales of the 
MFI-20 showed fair to moderate (women) and moderate to good (men) 
associations with the one-dimensional subscale of fatigue included in the 
Fibromyalgia Impact Questionnaire (FIQ), indicating sufficient convergent 
validity. In analyses of 36 women and 26 men with FM and CWP, the MFI-
20 was found to possess acceptable test-retest reliability and internal 
consistency. 
 II. The study included 133 women with FM. The subscales of the MFI-20 
were found to be associated with employment, physical activity and the 6-
minute walk test (6MWT) (p<0.01), while the FIQ fatigue was not. The MFI-
20 and the FIQ fatigue were equally associated with pain, sleep and distress 
(r p<0.01). Women with FM (n=133) rated their fatigue higher (p<0.001) 
than the healthy women (n=158) in all fatigue dimensions.  
III. The randomized controlled trial included 166 women with FM or CWP. 
The FIQ total (p=0.040) and the FIQ pain (p=0.018) improved in the 
exercise-education group as compared to the control group which only 
received education. Patients with at least 60% attendance in exercise sessions 
improved in the FIQ total, the 6MWT and the FIQ pain compared with 
controls (p<0.05). Analyses within subgroups showed that patients with 
milder stress, pain or distress improved most by exercise on the FIQ total 
(p<0.05) compared with controls. Patients with more severe symptoms 
appeared to improve equally regardless of the type of intervention. 
IV. The pilot study comprised 44 men with FM and CWP and 28 men with 
CWP were included in the main analyses of the randomized controlled trial. 
Resistance training improved isometric force in right arm shoulder abduction 
(p=0.010) and knee flexion (right: p=0.005, left: p=0.002) as compared to 
pool exercise. Within-group analyses showed that the resistance training 
group also improved in general fatigue (p=0.035) and right hand grip force 
(p=0-009) and the pool exercise group improved in MFI-20 reduced 
motivation (p=0.008) and symptoms of anxiety (p=0.032).  
Conclusions. The MFI-20 was found to possess sufficient test-retest 
reliability, convergent validity and internal consistency in patients with FM 
and CWP. Assessment of multiple fatigue dimensions appears to be most 
useful in relation to aspects of employment and physical function in female 
patients with FM. Physiotherapy including exercise and education appears to 
improve health, including some dimensions of fatigue, in patients with FM 
and CWP. 
Keywords: fatigue, fibromyalgia, chronic pain, widespread pain, assessment, 
physiotherapy, exercise, education 
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SAMMANFATTNING PÅ SVENSKA 
Syfte: Trötthet är ett stort problem för personer med fibromyalgi (FM) och 
långvarig generaliserad smärta (CWP). Syftet med avhandlingen var att 
beskriva tröttheten hos personer med FM och CWP, undersöka tillförlitlighet 
och användbarhet hos ett frågeformulär avsett att mäta flera dimensioner av 
trötthet (the Multidimensional Fatigue Inventory (MFI-20)) samt utvärdera 
effekten av sjukgymnastisk behandling hos personer med FM och CWP. 
Metod: 166 kvinnor och 44 män med FM eller CWP rekryterades till 
studierna, huvudsakligen från primärvården. I två metodstudier undersöktes 
tillförlitlighet och användbarhet hos MFI-20, för personer med FM och CWP. 
Jämförelser av trötthet gjordes också mellan olika grupper. I två 
randomiserade kontrollerade studier studerades också effekten av olika 
sjukgymnastiska behandlingsmetoder hos personer med FM och CWP. 
Resultat: I. 166 kvinnor med FM eller CWP deltog i studien. Extra analyser 
av validitet och reliabilitet hos MFI-20 gjordes i avhandlingen på 44 män 
med FM eller CWP. MFI-20 visade tillfredsställande och intern konsistens 
stabilitet över tid. MFI-20 dimensionerna visade signifikant samband med en 
endimensionell skala för global trötthet som ingår i Fibromyalgia Impact 
Questionnaire (FIQ fatigue). II. 133 kvinnor med FM deltog i analyserna av 
användbarheten hos MFI-20. MFI-20 visade signifikanta samband med 
arbetsgrad, fysisk aktivitetsnivå och gångförmåga, medan FIQ fatigue inte 
gjorde det. Både MFI-20 och FIQ fatigue samvarierade med smärta, sömn, 
nedstämdhet och ängslan. Kvinnor med FM (n=133) skattade sin trötthet 
högre än friska kvinnor (n=158) för alla dimensioner av trötthet.  
III. Patienter med FM eller CWP som deltog i bassängträning och utbildning 
(n=81), förbättrades signifikant i allmän hälsostatus och smärta, jämfört med 
patienter som endast deltog i utbildning (n=85). Patienter med mildare nivåer 
av stress, smärta och depression förbättrades mest av träningen. Patienter 
med svårare symtom uppvisade förbättring i hälsostatus oavsett behandling. 
IV. 44 män med FM eller CWP rekryterades till pilotstudien, och 28 män 
med CWP inkluderades i huvudanalysen av den randomiserade kontrollerade 
studien. Styrketräning förbättrade isometrisk styrka signifikant jämfört med 
bassängträning. Förbättringar av vissa dimensioner av trötthet kunde ses i 
analyser inom grupperna.  
Konklusion: MFI-20 uppvisade homogenitet och stabilitet över tid. Mätning 
av flera dimensioner av trötthet verkar vara mest användbart i relation till 
arbetsgrad, fysisk aktivitet och fysisk funktion. Sjukgymnastik, bestående av 
träning och/eller utbildning, förefaller förbättra hälsan, och även vissa 
dimensioner av trötthet, hos patienter med FM och CWP. 
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DEFINITIONS IN SHORT 
Chronic widespread pain The presence of pain on the left and right side 
of the body, above and below the waist and 
axial skeletal pain, for at least three months 
(Wolfe et al., 1990) 
Exercise A type of physical activity consisting of 
planned, structured and repetitive bodily 
movement done to improve or maintain one or 
more components of physical fitness 
(Thomson, 2009) 
Fibromyalgia The presence of chronic widespread pain and 
pain in at least 11 of 18 predefined tender 
points on manual palpation with a pressure of 
~4 kg (Wolfe, et al., 1990) 
Pain An unpleasant sensory and emotional 
experience associated with actual or potential 
tissue damage (Merskey & Bogduk, 1994) 
Patient education Planned organized learning experiences 
designed to facilitate voluntary adoption of 
behaviors or beliefs conducive to health 
(Burckhardt et al., 1994) 
Physical activity 
 
 
 
 
Physical function 
Any bodily movement produced by the 
contraction of skeletal muscles that results in 
a substantial increase over resting energy 
expenditure (Thomson, 2009) 
 
The capacity of an individual to carry out the 
physical activities of daily living (Garber et 
al., 2011)  
Reliability The degree of consistency and accuracy of an 
instrument (Polit & Tatano Beck, 2004) 
Repetition maximum The heaviest resistance that can be used for 
one complete repetition of an exercise (Fleck 
& Kraemer, 2004) 
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Resistance training A type of exercise that requires the body´s 
musculature to move (or attempt to move) 
against an opposing force, usually presented 
by some kind of equipment (Fleck & 
Kraemer, 2004) 
Validity The degree to which an instrument measures 
the concept it is supposed to measure (Polit & 
Tatano Beck, 2004) 
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1 INTRODUCTION 
Patients with fibromyalgia (FM) and chronic widespread pain (CWP) are 
common in primary health care. Their symptoms often have a complex 
etiology with multiple causes, which makes it challenging to find methods in 
health care to support these patients and continuous research is needed in the 
area. Thus, when the opportunity came to our primary care physiotherapy 
unit to enter a multicenter treatment study for patients with FM or CWP, we 
were positive and motivated to participate. 
This thesis arose from that treatment study (study III in this thesis) in which 
our research group developed a growing interest in fatigue. In the contacts 
with patients with FM or CWP, it became clear that fatigue was perceived as 
a great problem – perhaps equal to pain. Awareness of the importance of 
fatigue has increased in research on FM and CWP during the last decade. The 
perspective on the assessment of fatigue has also changed. There is a growing 
interest in ratings of multiple dimensions of fatigue instead of one global 
fatigue question, not only in studies of patients with pain but also in other 
somatic conditions. 
The studies in the present thesis describe the multidimensional fatigue 
experienced by patients with FM and CWP and investigate the usefulness of 
an instrument aimed to measure multiple dimensions of fatigue, the 
Multidimensional Fatigue Inventory (MFI-20).  Investigation were also made 
on the effects of different types of physiotherapy treatments on fatigue and 
other health related aspects in patients with FM. 
While FM has been considered in some theories to be a distinct disorder, 
recent research inclines toward the idea that the conditions of FM and CWP 
are parts of a severity continuum of pain and distress, along with other 
chronic pain conditions (J. N. Ablin et al., 2011; Staud, 2009; Wolfe & 
Michaud, 2009). Inclusion of both FM and CWP can be considered to 
increase the clinical value of the studies since the results will be able to be 
generalized to a broader target group. However, inclusion of only FM in 
studies differentiates a more homogenous group of patients with regard to 
intensity of symptoms, which facilitates research. 
Studies I, II and III in the present thesis included only women. There is a 
scarcity of studies of physiotherapy treatments for men with widespread pain. 
A pilot study was therefore initiated as study IV, which investigated the 
effects of two types of exercise in male patients with CWP. 
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2 BACKGROUND 
2.1 Criteria for chronic widespread pain and 
fibromyalgia 
In 1990, the American College of Rheumatology (ACR) defined criteria for 
CWP and FM. These were used as inclusion criteria for the study populations 
in this thesis. 
 
CWP was defined as the presence of pain, as follows, for at least three 
months: pain on the left side of the body, pain on the right side of the body, 
pain above the waist, pain below the waist and axial skeletal pain (cervical 
spine or anterior chest or thoracic spine or low back). 
In this definition, left or right shoulder and buttock pain was considered to be 
pain in each involved side. Low back pain was considered lower segment 
pain (Wolfe, et al., 1990).  
 
The ACR criteria for FM in 1990 were the presence of the following two 
conditions: 
- CWP (as described above)  
- Pain in at least 11 of 18 predefined tender points on manual palpation 
with a pressure of ~ 4 kg. (Wolfe, et al., 1990) (figure 1). 
New criteria for FM were developed in 2010. The new criteria were not 
meant to replace the 1990 criteria but to represent an alternative method of 
diagnosis in which the tender point criterion was excluded and all 
characteristic features of FM were taken into consideration (Wolfe et al., 
2010). The 2010 criteria for FM are in short defined as the presence of all of 
the following three conditions (Wolfe, et al., 2010): 
- Widespread pain index (WPI) ≥ 7 and symptom severity (SS) scale 
≥5 or WPI 3-6 and SS scale score ≥ 9. 
- Presence of symptoms at a similar level for at least three months. 
- Lack of a disorder that would otherwise explain the pain. 
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In the 2010 criteria above, WPI consists of a total of 19 predefined body 
areas and the score represents how many painful areas in which the patient 
has had pain during the most recent week (score 0-19). In the SS scale (score 
0-12) the level of severity over the past week is noted for the following three 
features: fatigue, waking unrefreshed and cognitive symptoms. The level of 
severity is rated on a Likert scale from 0 to 3, where 0 is no problem and 3 is 
severe problem. The extent of somatic symptoms in general is also noted in 
the SS scale, ranging from 0 to 3 where 0 is no symptoms and 3 is a great 
number of symptoms (Wolfe, et al., 2010). 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Locations of the tender points included in the 1990 American College of 
Rheumatology criteria for fibromyalgia. © Karen Lee Richards. Reprint courtesy of 
Karen Lee Richards. 
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The 1990 criteria for FM were used in the present thesis as inclusion criteria 
for the study populations and in all references to FM. The 1990 FM criteria 
were initially recommended for use in research. Later, the criteria were also 
applied in clinical practice (ICD-10 diagnosis M79.7) (J. Ablin, Neumann, & 
Buskila, 2008). The tender point criterion dichotomizes the patients with 
CWP into two groups: those who fulfill the criteria for FM and those who do 
not (Wolfe, et al., 2010). The 2010 criteria, on the other hand, make a more 
diffuse limit between FM and CWP. In physiotherapy, similar treatment 
strategies are often applied for FM and CWP and, in that context, the 2010 
criteria can be adequate for use in health care.  
2.2 Characteristics 
As mentioned above, FM and CWP are characterized by widespread pain and 
tenderness. Other important features are fatigue, sleep disturbances, stiffness, 
symptoms of depression and anxiety and cognitive difficulties (P. Mease et 
al., 2009; Rohrbeck, Jordan, & Croft, 2007; Wolfe, Ross, Anderson, Russell, 
& Hebert, 1995; Wolfe, et al., 1990).  
CWP has been shown to be associated with older age, being an immigrant, 
lower socio-economic class, lower educational level and family history of 
chronic pain (Bergman, 2005). The majority of patients with FM and CWP 
experience work limitations due to their pain, fatigue and cognitive 
symptoms (Henriksson, Liedberg, & Gerdle, 2005; White, Speechley, Harth, 
& Ostbye, 1999). However, with individual adjustments to their work 
conditions, many patients with FM manage to stay active at work 
(Henriksson, et al., 2005).  
Patients with FM have been shown to have impaired physical function, such 
as flexibility, strength, walking capacity (Mannerkorpi, Burckhardt, & Bjelle, 
1994), balance (Jones, Horak, Winters-Stone, Irvine, & Bennett, 2009) and 
oxygen uptake (Valim et al., 2002). A previous study investigated 
explanatory variables of self-reported high physical function in FM and 
showed that male gender, higher education, younger age, less fatigue and use 
of aerobic exercise or strength training were some of the explanatory 
variables of high self-rated physical function in FM (Rutledge, Jones, & 
Jones, 2007).  
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2.3 Prevalence 
Most FM and CWP population studies have been conducted in Western 
Europe and North America, for which reason there is a lack of knowledge 
about the prevalence of these conditions in other regions (Gran, 2003). The 
prevalence of FM and CWP also varies in different studies depending on 
definition of widespread pain, methods for recruitment, the country in 
question and even which part of the country the study is carried out. 
Fibromyalgia 
The prevalence of FM in the Western world has been estimated to be between 
1 % and 3 % of the population and is more prevalent in older ages and among 
women (Gran, 2003; Wolfe, et al., 1995).  
Among men, the prevalence of FM in the Western world has been found to 
be between 0.2 % and 1.6 %  and, among women, between 1.0 % and 4.9 % 
(Gran, 2003). 
Chronic widespread pain 
The prevalence of CWP in the Western world has been estimated to be between  
7 % and 13 % of the population (Gran, 2003). 
Among men, the prevalence of CWP has been found to be between 3 % (Gerdle 
et al., 2008) and 9 % (Bergman et al., 2001; Gran, 2003) and, among women, 
between 6.5 % (Gerdle, et al., 2008) and 16 % (Bergman, et al., 2001; Gran, 
2003). 
Widespread pain coexists in several other conditions. In rheumatic diseases such 
as rheumatoid arthritis, systemus lupus erythematosus and osteoarthritis, the 
prevalence of FM has been reported to be between 11 and 16 % and in myalgic 
encephalomyelitis (ME), the prevalence of FM has been estimated to be 55 % 
(Yunus, 2012). CWP has also been shown to be present in 28 % of women with 
chronic low back pain consulting primary health care (Nordeman, Gunnarsson, & 
Mannerkorpi, 2012). 
2.4 Etiology 
Pain is always subjective and can also be present when tissue damage is 
absent. The International Association for the Study of Pain (IASP) has 
defined pain as “an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage, or described in terms of such 
damage”(Merskey & Bogduk, 1994).  
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The pathogenesis of pain in FM is not entirely understood. 
Environmental factors such as physical trauma, certain infections, auto-
immune disorders, emotional stress and other regional pain conditions may 
play a role in the triggering and maintenance of widespread pain in FM 
(Clauw, 2007) but there may also be a familial component (Arnold et al., 
2004).  
Hyperalgesia and allodynia in FM have been shown to result from an 
increased sensitivity in central nervous mechanisms referred to as central 
sensitization (Clauw, 2007; Woolf, 2011). In central sensitization, 
nociceptive neurons of the dorsal horn become hyperresponsive to 
nociceptive, and sometimes non-nociceptive, somatic stimuli. This increased 
responsiveness leads to an increased input of signals to the cerebral cortex 
(Woolf, 2011). Central sensitivity syndromes or central pain conditions are 
concepts emerging in research, implying that several overlapping chronic 
pain conditions, such as FM, ME, irritable bowel syndrome, interstitial 
cystitis and tension-type headaches, may all be results of central sensitisation 
(Phillips & Clauw, 2011; Yunus, 2008). 
Descending pain inhibiting pathways from the brain stem, utilizing 
neurotransmitters, have been shown to be deficient in patients with chronic 
pain. This reduced inhibition of pain in combination with the increased input 
of pain signals are considered to cause the hyperalgesia found in FM.  
Other neurobiological aberrations have been observed in the hypothalamic-
pituitary-adrenal (HPA) axis and the noradrenaline-sympathetic system in 
patients with chronic pain, which are components of the human stress 
response. These two components have been shown to be hypo-reactive in 
FM, which is also considered to be a possible part of the pathogenesis of FM 
(Kadetoff & Kosek, 2010; Price & Staud, 2005).  
To conclude, the maintenance of widespread pain in FM is considered to be 
due to an increase in pain facilitation and a decrease in pain inhibition. These 
alterations are influenced by cognitions, emotions and behaviors (Nijs & Van 
Houdenhove, 2009). While the etiology of pain in patients with FM is under 
continuous study, there is limited knowledge of the cause of their fatigue. 
However, it has been suggested that the fatigue in FM can also be partly 
explained by central sensitization (Casale & Rainoldi, 2011; Yunus, 2007).  
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2.5 Fatigue 
Fatigue can be referred to as acute or chronic. The acute fatigue is considered 
a normal protective mechanism and is often relieved by rest or a change of 
habits. Chronic fatigue on the other hand is abnormal and non-functional, 
often with complex or unknown causes (Guymer & Clauw, 2002).  
Fatigue is a symptom of substantial importance for patients with FM 
(Guymer & Clauw, 2002; Yunus, 2007) and appears to be a major limitation 
both in their social life and for their work ability (Liedberg & Henriksson, 
2002; Sallinen, Kukkurainen, Peltokallio, & Mikkelsson, 2011; Wuytack & 
Miller, 2011). Patients with FM have described their fatigue in terms of 
sleepless nights, physical weakness, social withdrawal, loss of mental energy 
and overwhelming exhaustion (Sallinen, et al., 2011). 
Previous research indicates that fatigue levels in FM decrease with age 
(Wolfe, Hawley, & Wilson, 1996). Fatigue in fibromyalgia has been shown 
to be associated with other health related aspects, such as increased muscular 
tenderness, depression, poor sleep quality (Kurtze & Svebak, 2001; Nicassio, 
Moxham, Schuman, & Gevirtz, 2002; Wolfe, et al., 1996) and low level of 
physical activity and physical function (Kop et al., 2005; Rutledge, et al., 
2007), as well as socio-demographic aspects such as female gender, low age, 
low working capacity and low education. Previous research has indicated that 
high BMI may be associated with fatigue (Wolfe, et al., 1996), while recent 
studies show no relationship between BMI and fatigue in FM (Kim, Luedtke, 
Vincent, Thompson, & Oh, 2012; Okifuji, Bradshaw, & Olson, 2009). 
There are many conditions besides FM and CWP where chronic fatigue is a 
severe problem, such as other rheumatic diseases (Barendregt et al., 1998; 
Rupp, Boshuizen, Jacobi, Dinant, & van den Bos, 2004; van Tubergen et al., 
2002), myalgic encephalomyelitis (Carruthers et al., 2011), cancer (Furst & 
Ahsberg, 2001), neurological disorders (Catalan et al., 2011; Duncan, 
Kutlubaev, Dennis, Greig, & Mead, 2012) and psychiatric conditions 
(Ferentinos et al., 2011).  
Myalgic encephalomyelitis (ME), also referred to in the literature as chronic 
fatigue syndrome (CFS), is a complex condition characterized by an 
abnormally low threshold of fatigability after minimal physical or mental 
exertion. The pathophysiology of ME is believed to involve aberrations in the 
central nervous system, the immune system and the cellular energy 
metabolism as well as cardiovascular abnormalities (Carruthers, et al., 2011). 
ME occurs as a co-morbidity in patients with FM, but is also present in other 
conditions. As mentioned previously, about 55 % of ME patients have been 
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2002; Sallinen, Kukkurainen, Peltokallio, & Mikkelsson, 2011; Wuytack & 
Miller, 2011). Patients with FM have described their fatigue in terms of 
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tenderness, depression, poor sleep quality (Kurtze & Svebak, 2001; Nicassio, 
Moxham, Schuman, & Gevirtz, 2002; Wolfe, et al., 1996) and low level of 
physical activity and physical function (Kop et al., 2005; Rutledge, et al., 
2007), as well as socio-demographic aspects such as female gender, low age, 
low working capacity and low education. Previous research has indicated that 
high BMI may be associated with fatigue (Wolfe, et al., 1996), while recent 
studies show no relationship between BMI and fatigue in FM (Kim, Luedtke, 
Vincent, Thompson, & Oh, 2012; Okifuji, Bradshaw, & Olson, 2009). 
There are many conditions besides FM and CWP where chronic fatigue is a 
severe problem, such as other rheumatic diseases (Barendregt et al., 1998; 
Rupp, Boshuizen, Jacobi, Dinant, & van den Bos, 2004; van Tubergen et al., 
2002), myalgic encephalomyelitis (Carruthers et al., 2011), cancer (Furst & 
Ahsberg, 2001), neurological disorders (Catalan et al., 2011; Duncan, 
Kutlubaev, Dennis, Greig, & Mead, 2012) and psychiatric conditions 
(Ferentinos et al., 2011).  
Myalgic encephalomyelitis (ME), also referred to in the literature as chronic 
fatigue syndrome (CFS), is a complex condition characterized by an 
abnormally low threshold of fatigability after minimal physical or mental 
exertion. The pathophysiology of ME is believed to involve aberrations in the 
central nervous system, the immune system and the cellular energy 
metabolism as well as cardiovascular abnormalities (Carruthers, et al., 2011). 
ME occurs as a co-morbidity in patients with FM, but is also present in other 
conditions. As mentioned previously, about 55 % of ME patients have been 
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shown to fulfil the criteria for FM (Yunus, 2012). The patients described in 
this thesis were not examined for the ME criteria, and this condition will 
therefore not be further mentioned in this thesis. 
2.5.1 Assessment of fatigue  
Fatigue is an important domain in FM and recommended to be assessed in all 
clinical trials involving patients with FM (Choy et al., 2009). 
There are currently no accepted definition of fatigue in FM and CWP, which 
complicates its assessment (Casale & Rainoldi, 2011). The term fatigue often 
alludes to physical muscle fatigue, such as in healthy individuals where 
fatigue has been defined as “a condition related to an exercise-induced 
reduction in the ability to produce force, which determines whether the 
performance of the task can be sustained” (Barry & Enoka, 2007). 
It has been suggested that a distinction can be made between peripheral 
muscle fatigue and central fatigue in FM and that assessment of fatigue 
should include both subjective ratings and objective evaluation of local 
muscle fatigue with surface electromyography (Casale & Rainoldi, 2011). 
This thesis comprises only subjective ratings of perceived fatigue in patients 
with FM and CWP. The patients´ subjective experiences of fatigue might 
have a higher relevance for their well-being than objective measures. 
However, subjective experiences of fatigue fluctuate and are 
multidimensional, which complicates the assessment (Guymer & Clauw, 
2002; Smets, Garssen, Bonke, & De Haes, 1995; Watt et al., 2000); it is also 
difficult to compare between two individuals. In research, group comparisons 
of fatigue are carried out continuously between different populations and 
conditions. In such comparisons it is important to take into consideration that 
different conditions bring different experiences of fatigue. The patients´ 
experiences affect their frames of references for severe fatigue and influence 
their ratings. 
Dimensions of fatigue 
The traditional way to subjectively rate fatigue has been to use a one-
dimensional visual analogue scale (VAS). When the perspective on 
assessments of fatigue started to change, instruments intended to measure 
multiple dimensions of fatigue were developed. The complexity of fatigue 
favors the use of multiple dimensions. It is possible that different treatments 
could have an impact on different dimensions of fatigue, which can be 
studied when ratings of multiple dimensions are used in research.  There is no 
consensus on how many dimensions of fatigue exist. Most fatigue scales 
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therefore differ in which and how many dimensions of fatigue they comprise, 
probably due to the group of patients for which they are constructed.  
The Multidimensional Fatigue Inventory (MFI-20) 
The MFI-20 is a self-administered instrument that comprises five dimensions 
of fatigue: general fatigue, physical fatigue, mental fatigue, reduced activity 
and reduced motivation. 
The MFI-20 was originally developed to assess cancer-related fatigue (Smets, 
et al., 1995). The construct validity of the instrument was assessed in 
comparisons between and within populations hypothesized to differ in 
different dimensions of fatigue, such as cancer patients receiving 
radiotherapy, patients with CFS/ME, psychology students, medical students, 
army recruits and junior physicians. The structure of five different fatigue 
dimensions was investigated using confirmatory factor analyses. The MFI-20 
was also investigated for convergent validity by correlation with a VAS for 
fatigue in cancer patients as well as internal consistency for all populations 
described above. The results indicated satisfactory reliability and validity for 
assessment of cancer-related fatigue (Smets, et al., 1995). 
The MFI-20 was translated to Swedish in a study of cancer patients receiving 
radiotherapy. The internal consistency of the subscales of the Swedish 
version of the MFI-20 was also investigated in the study and was found to be 
satisfactory for patients with cancer (Furst & Ahsberg, 2001).  
At the time when the studies in the present thesis were planned, there was no 
accepted assessment tool for multidimensional fatigue for use in FM. 
However, the MFI-20 had been used in several other chronic pain conditions, 
such as rheumatoid arthritis (Rupp, et al., 2004), primary Sjögren´s syndrome 
(Barendregt, et al., 1998) and ankylosing spondylitis (van Tubergen, et al., 
2002). It was thus chosen to assess multidimensional fatigue in this thesis. 
The MFI-20 has recently been recommended for use in patients with FM 
(Choy, et al., 2009) and has also been used in pharmacological studies in FM 
(Arnold et al., 2010). However, the Swedish version of the MFI-20 had not 
been validated or tested for reliability in patients with FM, and, for this 
reason, Study I in the present thesis was initiated.  
The MFI-20 is more comprehensive and time-consuming than a one-
dimensional scale. The Fibromyalgia Impact Questionnaire (FIQ) is an 
accepted tool for measuring self-rated symptoms and disabilities in FM, and 
it includes a one-dimensional VAS for fatigue. For both ethical and practical 
reasons, patients should not be subjected to unnecessarily extensive 
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questionnaires. It is therefore of interest to investigate the contexts in which it 
is indicated to add the more comprehensive MFI-20 to the patient 
examination and when the one-dimensional FIQ fatigue is sufficient, and this 
was the reason for initiating Study II in the present thesis. 
2.6 Gender differences  
FM and CWP are more prevalent among women than men (Bergman, et al., 
2001; Gerdle, et al., 2008; Gran, 2003). Female patients with FM have been 
shown to have more tender points than male patients with FM (Hauser et al., 
2011; Yunus, Inanici, Aldag, & Mangold, 2000). 
No gender differences have been found in socio-demographic aspects such as 
age, marital status and education (Hauser, et al., 2011), or in health related 
aspects such as pain intensity and symptoms of depression and anxiety 
(Hauser, et al., 2011; Yunus, 2001). 
However, there appear to be gender differences in ratings of fatigue in FM, 
where several studies have shown that women report higher fatigue levels 
than men (Nicassio, et al., 2002; Wolfe, et al., 1996; Yunus, 2001). There 
appears to be a gender difference with regard to fatigue in the general 
population as well (Watt, et al., 2000). 
An epidemiological study showed that the strongest explanatory variable for 
high self-rated physical function in FM was being a man and that 27 % of 
men with FM were highly functioning compared to only 12 % of the women 
(Rutledge, et al., 2007).  
Most studies of patients with CWP and FM concern female patients only or a 
mix of men and women where the men are in minority. Since there appear to 
be gender differences in ratings of fatigue and physical function it might be 
preferable to study the effects of treatment in men and women separately. 
This conclusion is supported by a previous study suggesting that men retain 
positive effects in pain and distress after chronic pain management 
programmes longer than women (Keogh, McCracken, & Eccleston, 2005) 
2.7 Treatment  
There is no cure for FM and CWP as yet, and the treatment is mainly 
symptomatic. The European league against rheumatism (EULAR) has 
suggested guidelines for treatment in FM (Carville et al., 2008). The most 
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efficacious treatment of FM requires a multidisciplinary approach combining 
pharmacological treatment, exercise and cognitive behavioral therapy 
(Carville, et al., 2008; Kosek & Löfgren, 2009; Sarzi-Puttini et al., 2011). 
Both pharmacological and non-pharmacological treatments have been shown 
to have an effect on symptom severity and physical function. The treatments 
need to be tailored with consideration to pain, fatigue, function and other 
features associated with FM (Busch, Barber, Overend, Peloso, & Schachter, 
2007; Carville, et al., 2008; Mannerkorpi & Henriksson, 2007). 
2.7.1 Physiotherapy 
The main objective of physiotherapy treatment is to promote health. The 
physiotherapist should regard the patient as a physical, psychic, social and 
existential whole (Broberg & Tyni-Lenné, 2009). Physiotherapy was 
described in 2007 by the World Confederation for Physical Therapy (WCPT) 
as follows: 
”Physical therapy provides services to individuals and populations to 
develop, maintain and restore maximum movement and functional ability 
throughout the lifespan. This includes providing services in circumstances 
where movement and function are threatened by ageing, injury, disease or 
environmental factors. Functional movement is central to what it means to be 
healthy.”(WCPT, 2007) 
The description above illustrates that physiotherapy needs to include many 
dimensions. According to the WCPT, physiotherapy involves “identifying 
and maximising quality of life and movement potential within the spheres of 
promotion, prevention, treatment/intervention, habilitation and rehabilitation“ 
(WCPT, 2007). 
As mentioned, a multidisciplinary approach is recommended for patients with 
FM and CWP. However, many patients with widespread pain in primary 
health care may be in need of physiotherapy as their only treatment form 
(Nijs, Mannerkorpi, Descheemaeker, & Van Houdenhove, 2010). Primary 
care physical therapy is recommended to include aerobic exercise, 
strengthening exercise and education. There is less evidence for the use of 
passive treatments, relaxation and activity management (Nijs, et al., 2010). 
Exercise 
Exercise has been defined as “a type of physical activity consisting of 
planned, structured and repetitive bodily movement done to improve or 
maintain one or more components of physical fitness” (Caspersen, Powell, & 
Christenson, 1985; Thomson, 2009), where physical activity means “any 
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bodily movement produced by the contraction of skeletal muscles that results 
in a substantial increase over resting energy expenditure” (Thomson, 2009). 
The concept physical function is also used in the present thesis, which has 
been defined as “the capacity of an individual to carry out the physical 
activities of daily living” (Garber, et al., 2011) and reflects motor function 
and control, physical fitness, and habitual physical activity (Garber, et al., 
2011). 
Different types of exercise are being used for FM and CWP in health care, 
such as aerobic exercise, resistance training, flexibility exercise and body 
awareness therapy (Busch, et al., 2007). Engagement in exercise has been 
shown to be a strong explanatory variable of high self-rated physical function 
in patients with FM (Rutledge, et al., 2007). Aerobic exercise has been shown 
to improve global outcome measures, physical function and, to some degree, 
also pain and the number of tender points in FM (Busch, et al., 2007). There 
is limited evidence for the effect of resistance training and flexibility exercise 
in FM (Busch, et al., 2007). Only a few exercise studies have included 
measures of fatigue in FM patients, indicating that exercise can decrease 
fatigue levels (Jones et al., 2008; Pedersen & Saltin, 2006).  
Pool exercise is one type of aerobic exercise that has been recommended for 
patients with FM (Carville, et al., 2008) and been shown to improve physical 
function and overall health in FM and CWP (Carville, et al., 2008; 
Mannerkorpi & Henriksson, 2007). 
Pool exercise is commonly performed in temperate water (30-34 ºC) for 
patients with pain, which appears to reduce pain and stiffness and enhance 
relaxation. The viscosity of the water provides resistance to the exercises, 
while the buoyancy facilitates them (Mannerkorpi & Iversen, 2003).  
In patients with FM, aerobic exercise has been recommended to be performed 
two times a week in sessions between 20 to 60 minutes for at least six weeks 
(Busch, et al., 2007; Hauser et al., 2010). Patients with FM often experience 
increased pain and fatigue following exercise. However, if they continue to 
exercise for a few weeks at appropriate intensity, the symptoms most likely 
decrease again. It is thus important that the patients are informed of this 
initial increase in symptom severity before starting an exercise programme in 
order to keep them motivated to continue (Hauser, et al., 2010).  
Previous findings show that patients with more severe pain and physical 
impairments obtain the best effects from operant and cognitive behavioral 
treatment programmes (Thieme, Turk, & Flor, 2007) while, to the best of our 
knowledge, there are no studies that report which patients with FM or CWP 
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benefit most from physical exercise. Study III in the present thesis was 
initiated to explore this subject in sub-group analyses. 
Resistance training has been described as “a type of exercise that requires the 
body´s musculature to move (or attempt to move) against an opposing force, 
usually presented by some kind of equipment” (Fleck & Kraemer, 2004). 
There is a scarcity of studies concerning resistance training in patients with 
FM, and there is limited evidence of positive effects on symptom severity  
and physical function (Busch, et al., 2007). There is even less knowledge 
about effects of exercise in men with FM or CWP. This was the motivation 
for Study IV. There are no standardized recommendations for resistance 
training in patients with FM and CWP, and the resistance training programme 
in Study IV in the present thesis was therefore based mainly on 
recommendations for healthy individuals (Ratamess, Alvar, & Evetoch, 
2009). 
For healthy adults, a resistance training programme has been recommended at 
a minimum of two times a week in sessions between 20 and 60 minutes for at 
least six weeks and to include exercises with concentric, excentric and 
isometric muscle actions. Resistance training has also been recommended to 
involve  both unilateral and bilateral single-joint and multiple-joint exercises 
for maximizing strength (Ratamess, et al., 2009).  
Progression in resistance training has been defined as “the act of moving 
forward or advancing toward a specific goal over time until the target goal 
has been achieved” (Kraemer et al., 2002). Progression in resistance training 
in  healthy individuals has been recommended to be dependent on individual 
goals and guided by a specialist (Ratamess, et al., 2009).  
Patient education 
Patient education is a common treatment in many chronic conditions 
(Weingarten et al., 2002) and has been defined as “planned, organized 
learning experiences designed to facilitate voluntary adoption of behaviors or 
beliefs conducive to health” (Burckhardt, Lorig, et al., 1994).  
Education can be conducted in many forms, usually between physiotherapist 
and patient and interactions between patients. Different forms of education 
over the internet have recently become common (Burckhardt, 2005; Lorig et 
al., 2008). 
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In FM, education programmes have been recommended to be 
multidisciplinary and enhance a self-efficacy change in relation to healthy 
behaviors. Three general assumptions are suggested to guide the treatment of 
patients with FM: “that patients need skills for managing their symptoms on a 
day-to-day basis, that they can learn how to manage their fibromyalgia 
symptoms, and that effective practice of healthy behaviors will lead to 
positive changes in symptoms and health status” (Burckhardt, 2005). 
Education including cognitive behavioral techniques is recommended to be 
combined with exercise in order to be most effective in FM (Burckhardt, 
2005; Mannerkorpi, Nyberg, Ahlmen, & Ekdahl, 2000; Rooks et al., 2007) 
2.7.2 Pharmacological treatment 
Pharmacological treatment has been shown to be effective in some patients 
with FM, while showing no effect in many patients. Different types of 
medications are being studied continuously. Medications affecting the central 
nervous system are considered to be the most effective in pharmacological 
treatment in FM (Goldenberg, 2007; P. J. Mease, Dundon, & Sarzi-Puttini, 
2011).   
Serotonin-nonepinephrine reuptake inhibitors (SNRI), such as duloxetine, 
and anti-epilectic drugs, such as pregabalin and gabapentin, have been 
recommended for use in FM because of their effect on pain, physical function 
and general well-being (Carville, et al., 2008; Kosek & Löfgren, 2009; P. J. 
Mease, et al., 2011). There is limited evidence that selective serotonin 
reuptake inhibitors (SSRI) have also been shown to have effect on pain, 
fatigue, mood and function in patients with FM (Goldenberg, 2007). 
Low doses of tricyclic antidepressants (TCAs) have also been recommended 
for patients with FM (Goldenberg, 2007; Kosek & Löfgren, 2009). TCAs 
have shown a mild improvement in fatigue in patients with FM and moderate 
improvement in other features such as pain, sleep and general well-being 
(Goldenberg, 2007). Analgesics are often ineffective in patients with FM, 
except for tramadol, which has been shown to have a positive effect on pain 
and function in some patients with FM (Carville, et al., 2008; Kosek & 
Löfgren, 2009). 
Combinations of antidepressants, analgesics and anti-epileptic drugs are 
frequently used in practice, but such drug combinations have not yet been 
sufficiently studied (Goldenberg, 2007; P. J. Mease, et al., 2011).  
In conclusion, there are various pharmacological treatments that are 
recommended for use in FM. The EULAR recommends tramadol and 
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different types of TCAs, SNRI and anti-epileptic drugs (Carville, et al., 
2008). However, for many patients, medications have limited or no effect, 
and thus pharmacological treatment must be combined with exercise and 
cognitive behavioral therapy (Carville, et al., 2008; Goldenberg, 2007; Kosek 
& Löfgren, 2009). 
2.8 Methodological considerations 
2.8.1  Validity 
The validity of a study concerns whether the findings of the study are 
convincing and well-grounded. The design of the study is crucial for the 
validity of the study results (Polit & Tatano Beck, 2004). 
The validity of an instrument or a scale refers to the degree to which it 
measures the concept it is supposed to measure. There are several aspects that 
must be considered when the validity of an instrument is established: content 
and face validity, criterion validity and construct validity (Polit & Tatano 
Beck, 2004; Streiner & Norman, 2008). 
Face validity and content validity are closely related concepts and describe 
whether the scale seems to be reasonable (Streiner & Norman, 2008). Face 
validity refers to whether an instrument appears on the surface to assess the 
concept in question (Polit & Tatano Beck, 2004). Content validity concerns 
whether the instrument appears to include all the important and necessary 
aspects of the concept in question (Streiner & Norman, 2008). Criterion 
validity refers to the instrument’s relationship with an external criterion, often 
a “gold standard”(Streiner & Norman, 2008). 
Construct validity 
Construct validity describes the extent to which the instrument adequately 
assesses the concept of interest (Polit & Tatano Beck, 2004). When the 
purpose of an instrument is to assess an abstract concept, such as fatigue, it is 
important to consider the construct validity of the instrument (Streiner & 
Norman, 2008). The construct validity of an instrument is often divided into 
convergent validity and discriminant validity, which describes the 
relationship between the instrument and other scales or methods of 
measurement (Polit & Tatano Beck, 2004; Streiner & Norman, 2008). High 
convergent validity of an instrument requires a high correlation between the 
instrument and another measurement assessing the same concept of interest 
(Streiner & Norman, 2008). High discriminant validity (or divergent validity) 
of an instrument requires a low correlation between the instrument and 
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another measurement assumed to be unrelated to the concept of interest 
(Streiner & Norman, 2008). 
Another approach of construct validation is known-groups technique. 
Known-group validity is determined by the degree to which an instrument 
can demonstrate different scores for groups expected to vary on the variables 
being measured (Polit & Tatano Beck, 2004). 
2.8.2  Reliability 
Reliability refers to the accuracy and consistency of the information obtained 
in a study (Polit & Tatano Beck, 2004). There are several types of reliability 
of measurement, and the two aspects that will be described below are test-
retest reliability and internal consistency. 
Test-retest reliability 
The stability of an instrument is often referred to as test-retest reliability and 
is established by investigating whether a self-administered instrument gives 
the same result on two different occasions. The time between the two 
occasions is crucial and needs to be chosen with respect to the specific 
concept of interest to prevent the influence of extraneous variables. High test-
retest reliability of an instrument requires a high correlation between the 
results on the two occasions (Polit & Tatano Beck, 2004).  
Internal consistency 
Internal consistency concerns the extent to which the items of a scale all 
measure the same concept (Pallant, 2010). When a scale consists of  several 
subscales that assess different but related concepts, the internal consistency 
should be assessed separately for the subscales (Polit & Tatano Beck, 2004). 
2.8.3  Responsiveness 
It is necessary in experimental studies that the instruments used for 
evaluation of possible effects of the intervention have the ability to detect 
changes in the outcome variables. The responsiveness of an instrument has 
been described as its ability to detect clinically relevant and meaningful 
changes in the concept of interest (Streiner & Norman, 2008). Another 
commonly used term is sensitivity to change, which has been described as the 
instrument’s ability to detect any changes at all in the concept of interest, 
regardless of whether the changes are clinically relevant (Streiner & Norman, 
2008). 
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3 AIM 
3.1 General aims 
The general aims of this thesis were to describe the multi-dimensional fatigue 
experienced by patients with FM and CWP, to explore the usefulness of the 
MFI-20 in women with FM and to investigate the effects of different types of 
physiotherapy on fatigue and other health related aspects in patients with FM 
and CWP.  
3.2 Specific aims 
I. To investigate the convergent construct validity and test-retest 
reliability of the Swedish version of the MFI-20 for female 
patients with FM and CWP 
II. To explore the context in which ratings of multiple dimensions of 
fatigue (MFI-20) are useful in women with FM by comparing the 
MFI-20 and the one-dimensional FIQ fatigue in associations with 
socio-demographic and health related aspects and analyses of 
explanatory factors of severe fatigue  
To compare multiple dimensions of fatigue between women with 
FM and age matched healthy women. 
III. To investigate the effects of supervised physical exercise on 
health status and physical function in female patients with FM or 
CWP, and to analyse whether the level of pain, distress, stress 
and activity limitations might influence the outcomes 
IV. To investigate the effects of pool exercise in temperate water and 
resistance training in men with CWP on multidimensional 
fatigue, symptoms of distress and isometric force, pain and 
health related quality of life. 
Additional aims 
To investigate the internal consistency of the Swedish version of 
the MFI-20 in female and male patients with FM and CWP and 
the convergent construct validity and test-retest reliability in male 
patients with FM and CWP. 
To compare multiple dimensions of fatigue between men and 
women with CWP. 
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4 PATIENTS AND METHODS 
The present thesis comprises four quantitative studies, The primary methods 
used are briefly described in Table 1. 
Table 1.  Methods used in studies I, II, III and IV  
Study I II III IV 
Design Measurement 
study 
Cross-sectional 
study 
RCT RCT 
Pilot study 
Population Female, n=166 
Validity: n=166 
(134 FM, 32 
CWP) 
Reliability: n=36 
(28 FM, 8 CWP) 
 
Female, n=291 
Patient group:  
133 FM 
Reference group:
158 healthy 
women  
 
Female, n=166 
(134 FM, 32 
CWP) 
 
 
 
 
Male, n=38  
Randomized 
trial:  
28 CWP 
Reference  
group: 10 CWP
 
Outcomes MFI-20 
FIQ fatigue 
 
 
 
 
MFI-20 
FIQ fatigue 
Socio-
demographic and 
health related 
variables 
Primary: 
FIQ total, 6MWT
Secondary: 
FIQ pain, FIQ 
fatigue,HADS, 
SF-36, LTPAI 
Primary: 
MFI-20 
Secondary: 
HADS 
Isometric force 
 
Data 
analyses 
Validity: 
Spearman´s rho 
Reliability: 
ICC, LOA, IISD 
*Internal 
consistency: 
Cronbach´s 
alpha 
 
Spearman´s rho 
Multivariate 
logistic 
regression 
Between group: 
Mann-Whitney  
U-test 
 
 
Between-group:  
Mann-Whitney  
U-test, Fisher´s 
exact test  
Mantel- 
Haenszel χ2 test 
 
 
 
Between-group:
Kruskal Wallis  
test 
Mann-Whitney 
U-test,  
Fisher´s exact 
test, Mantel- 
Haenszel χ2 
test 
FM=fibromyalgia, CWP=chronic widespread pain, MFI-20=Multidimensional 
Fatigue Inventory, FIQ=Fibromyalgia Impact Questionnaire, 6MWT=Six-minute 
Walk Test, HADS=Hospital Anxiety and Depression Scale, SF-36=Short-Form 36 
health survey, LTPAI=Leisure Time Physical Activity Instrument, 
ICC=Intra class Correlation Coefficient, LOA=Limits of Agreement, IISD=Intra-
Individual Standard Deviation, RCT=Randomized Controlled Trial 
*Additional analysis in this thesis, not included in paper I 
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4.1 Populations 
The thesis had two main populations, referred to as the female population and 
the male population (Figure 2). The female population (n=166) was included 
as a whole or in parts in Studies I, II and III. A reference group of healthy 
women (n=158) was also recruited to Study II. The male population (n=44) 
was included in Study IV, although only the 38 patients with CWP in the 
male population were included in the main analyses in Study IV. Both 
populations were also included in additional analyses described below. 
 
Figure 2.   The populations in the present thesis 
 
4.1.1 Female population 
The female population was recruited from primary health care centres in 
Western Sweden by searching patient journals for the diagnoses of FM, CWP 
and unspecific pain (between 1995 and 2004) and by consecutive recruitment 
(in 2004 and 2005).  
The inclusion criteria were women with FM or CWP according to the ACR 
1990 criteria (Wolfe, et al., 1990), in the age range 18–60 years. 
The exclusion criteria were other severe somatic or psychiatric disorders, 
such as cancer, stroke or schizophrenia, inability to understand Swedish, 
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allergy to chlorine, ongoing exercise therapy supervised by a physical 
therapist, or plans to start such therapy during the study period.  
A systematic search of patient journals identified 818 subjects who had 
diagnoses related to pain disorder. However, when the journals were 
scrutinized, 520 individuals did not fulfil the inclusion criteria for FM or 
CWP or fulfilled exclusion criteria. The remaining 298 potentially eligible 
individuals were contacted by post (n=55) or telephone (n=243) for further 
screening. Forty-eight persons could not be contacted, 35 did not meet the 
inclusion criteria, and 61 declined to participate in the study, while 154 
agreed to participate in an examination. Twenty-two of them did not meet the 
inclusion criteria, 12 were excluded due to treatment in progress (n=3) or 
severe disorders (n=9) and 18 declined to participate. 
In total, 102 patients were referred to the intervention study and one patient 
was excluded for not fulfilling the inclusion criteria, leaving a total of 101 
patients. At the same time, 93 individuals were consecutively recruited to the 
study. Sixty-five of them fulfilled the criteria and agreed to participate in the 
study. The study population therefore comprised 166 patients, 134 of whom 
fulfilled the criteria for FM and 32 for CWP. 
Study I 
The whole female population (n=166) participated in the validity study and 
48 of the 166 patients were recruited to the reliability study. Sixteen per cent 
(n=7) of the patients in the test-retest reliability study did not complete and 
return the MFI-20 on the second occasion, and 8% (n=4) were excluded 
because the time between test 1 and test 2 exceeded two days. The final 
number of patients participating in the reliability study was 36 (28 FM, 8 
CWP). 
Study II 
Patient group. 133 patients with FM from the female population were 
included in Study II.  
Healthy reference group. A total of 189 healthy women between 21 and 60 
years of age were recruited to an age and sex matched reference group from a 
mammography screening centre (n=83) and from employees in the public 
sector (n=106). Twenty persons were excluded from the reference group due 
to exclusion criteria: pregnancy (n=2) and severe psychiatric or somatic 
disorders (n=18). Eleven persons aged 21-30 years were randomly excluded 
to achieve adequate age matching with the patient group. The remaining 158 
persons constituted the reference group in Study II. 
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Study III 
All patients in the female population (n=166) were recruited to the 
randomized trial in Study III. The patients were allocated to one of the two 
treatment programmes using stratified randomization for the disorder, FM or 
CWP (Pocock & Simon, 1975) (See flow-chart in Figure 3).  
The exercise-education group. 81 patients in the female population were 
allocated to the intervention group that participated in exercise and education. 
The education group. 85 patients in the female population were allocated to 
the control group that participated only in education. 
 
Figure 3. Flow chart for the patient population in Study III 
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Additional analyses female population 
The internal consistency of the Swedish version of the MFI-20 was calculated 
here for the whole female population (n=166) as a complement to the 
analyses of convergent validity and test-retest reliability in Study I. 
The 32 female patients with CWP were also included in an additional 
analysis that compared the scores of the MFI-20 and FIQ fatigue between 
men and women with CWP. 
4.1.2 Male population 
Study IV 
The total male population recruited to the pilot study included 44 men, six 
with FM and 38 with CWP. The male population comprised two different 
parts; the patients that were included in the randomized trial and the patients 
that were included in the reference group. 
The inclusion criteria for both parts were male patients, 18 to 60 years of age, 
with CWP according to the ACR criteria (Wolfe, et al., 1990). The exclusion 
criteria were inability to understand Swedish, severe psychiatric or somatic 
disorders, such as other rheumatic diseases, neurologic conditions, cancer, 
diagnosed depression or panic disorder, or having participated in resistance 
training or pool exercise at a physical therapy clinic during the preceding six 
months. 
The randomized trial. The patients in the randomized trial were recruited 
from primary health care centres in Uddevalla in Western Sweden by 
searching through patient journals for the diagnoses of CWP and FM and 
unspecific pain (between 2005 and 2007) and consecutive recruitment (in 
2008). Thirty-four patients (28 CWP, 6 FM) were allocated to one of the two 
exercise programmes using stratified randomization for the disorders of CWP 
or FM (Pocock & Simon, 1975). The recruitment process for the ramdomized 
trial is shown in the flow chart in Figure 4.  
The six men with FM were found to create a small subgroup with greater 
impairments than the patients with CWP. They tended to report more severe 
fatigue, pain, stress and distress (paper IV) than the patients with CWP, and 
isometric force appeared to be lower for the patients with FM than for the 
patients with CWP at baseline in all performance-based tests. Thus, to 
achieve a more homogenous study sample, the FM patients were excluded 
from the data analysis (Figure 1). The final number of patients included in the 
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randomized trial was 28, 14 in the pool exercise group and 14 in the 
resistance training group, all classified as CWP (Figure 4). 
The reference group. The reference group of male patients with CWP was 
recruited in parallel from different primary health care centres than the 
exercise groups in the western part of Sweden by searching patient journals 
for FM, CWP and unspecific pain diagnoses (between 2005 and 2007) and 
consecutive recruitment (in 2008). The recruitment process for the reference 
group is shown in Figure 5). The purpose of the reference group was to 
obtain information about the natural course of CWP during the study period. 
The number of patients included in the reference group was ten, all classified 
as CWP. The reference group did not participate in any intervention. 
Additional analyses male population 
Convergent construct validity, test-retest reliability and internal consistency 
were calculated in the present thesis for the Swedish version of the MFI-20 
for men with FM or CWP, as a complement to the analyses in Study I that 
included only female patients. 
The whole male population (n=44) participated in the analyses of convergent 
validity and internal consistency of the MFI-20. Forty of them were recruited 
to the test-retest reliability study. Sixteen per cent (n=7) of the patients in the 
test-retest reliability study did not complete and return the MFI-20 on the 
second occasion and 13% (n=5) were excluded because the time between test 
1 and test 2 exceeded two days. The final number of patients participating in 
the reliability study was 26 (5 FM, 21 CWP). 
The 38 male patients with CWP were also included in an additional analysis 
comparing the scores of the MFI-20 and FIQ fatigue between men and 
women with CWP. 
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Figure 4. Flow chart for the randomized trial of men with FM and CWP in Study IV. 
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Figure 5.  Flow chart for the reference group of men with CWP in Study IV 
4.2 Measurements 
In 2009, the international research group for Outcome measures in 
rheumatology (OMERACT) suggested key domains for FM, including 
recommendations for which domains should be assessed in clinical trials (P. 
Mease, et al., 2009). A hierarchy for the assessment of different domains in 
FM was suggested (Figure 6) (P. Mease, et al., 2009). 
According to this hierarchy, pain, tenderness, fatigue, patient global, 
multidimensional function and sleep disturbance are recommended to be 
assessed in all clinical trials (P. Mease, et al., 2009). Study III and Study IV 
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in this thesis appear to have embraced all these aspects as well as symptoms 
of depression, which are recommended to be included in some FM trials, and 
anxiety, which according to the hierarchy may or may not be included. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Hierarchy of domains for fibromyalgia. The inner circle includes the core set of 
domains to be assessed in all clinical trials of FM. The second concentric circle includes 
the outer core set of domains to be assessed in some but not all FM trials. The outermost 
circle includes the domains on the research agenda that may or may not be included in 
FM trials. (Mease, P et al.. published in J Rheumatol 36(10): 2318-2329) © Journal of 
Rheumatology. Reprint courtesy of Journal of Rheumatology. 
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The measurements used in the thesis are listed in Table 2 and presented in 
detail below 
Table 2. Overview of measurements in the thesis. 
Measurements Study I 
Study 
II 
Study 
III 
Study 
IV 
Self-administered questionnaires     
    MFI-20 [5 subscales à 4-20] X X X X 
    FIQ total [0-100]   X  
    FIQ fatigue [0-100] X X  X 
    FIQ pain [0-100]  X X X 
    Pain localizations [0-18]  X X X 
    HADS-Anxiety [0-21]  X X X 
    HADS-Depression [0-21]  X X X 
    SF-36 [0-100]  X X X 
    LTPAI [hours]  X X  
    SCI-93 [0-140]   X  
    Experience of physical activity [0-7]   X  
    Sleep quantity [1-4]  X   
    Sleep quality  [1-4]  X   
    BRPE [6-20]   X X 
Examinations     
    Tender points [0-18] X X X X 
    Pain pressure treshold [kPa/sec]   X  
    Body mass index (BMI) [kg/m2] X X X X 
Performance-based tests     
    Six-minute walk test (6MWT) [m]  X X  
    Isobex, shoulder abduction  [N]    X 
    Steve Strong, knee extension [N]    X 
    Steve Strong, knee flexion [N]    X 
    Grippit [N]  X  X 
HADS= The Hospital Anxiety and Depression Scale, SF-36=Short Form 
36 health survey, LTPAI= Leisure Time Physical Activity Instrument, SCI-
93=Stress and Crisis Inventory, BRPE= Borg scale for rating perceived 
exertion 
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The Hospital Anxiety and Depression Scale (HADS). The HADS contains 14 
statements, with a rating from 0 to 3, in which a higher score indicates a 
higher degree of distress. The scores build two subscales, for anxiety 
(HADS-A) and depression (HADS-D), ranging from 0 to 21 (Zigmond & 
Snaith, 1983). The cut-off score of eight is suggested to indicate possible 
anxiety and depression (Herrmann, 1997).  
Short Form-36 (SF-36). The SF-36 is a generic instrument assessing health 
related quality of life, comprising eight subscales. The subscales of physical 
functioning, role physical, bodily pain and vitality range from 0 to 100 and 
were used in study III in the present thesis. The eight subscales build two 
composite scores, the Physical Component Summary (PCS) and the Mental 
Component Summary (MCS), ranging from 0 to 100. The PCS and the MCS 
were used in studies III and IV in the present thesis. A higher score indicates 
better health related quality of life (Ware & Sherbourne, 1992). 
Leisure Time Physical Activity Instrument (LTPAI). This instrument assesses 
the amount of physical activity during a typical week, divided into light and 
moderate and vigorous. The sum of hours of moderate exercise was used in 
study III in the present thesis. The total score is the sum of hours for the 
activities and it was used in studies II and III in the present thesis 
(Mannerkorpi & Hernelid, 2005).  
Stress and Crisis Inventory (SCI-93). The SCI-93 comprises 35 items, 
assessing clinical manifestations of stress on a scale ranging from 0 “not at 
all” to 4 “very much”. The questions include physical and mental sensations. 
The total score ranges from 0 to 140 and a higher score indicates more stress 
(Krafft & Nystrom, 2002).  
Experience of physical activity. This scale consists of 22 items that comprise 
five subscales about aspects related to physical activity: activity-related 
physical relaxation (AR), activity-related well-being (AW), activity beliefs 
(AB), activity-related symptoms (AS) and activity habits (AH). The 
subscales range from 0 to 7 and a higher score indicates more dissatisfaction 
(Mannerkorpi, Rivano-Fischer, Ericsson, Nordeman, & Gard, 2008).  
Sleep quantity and quality. Two questions about the patients´ quantity and 
quality of sleep (Akerstedt et al., 2002) were used; “Do you think you get 
enough sleep?” and “On the whole, how do you think you sleep?” The scores 
range from 1 to 4 and a higher score indicates poorer sleep. 
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Background data  
The background data on the patients were collected in the same way in all 
four studies of the thesis. 
Information about socio-demographics, duration of widespread pain and 
pharmacological treatment was gathered in a standardized interview.  
Marital status was divided into two categories referring to whether the 
patient lived with another adult. 
Employment was divided into four categories referring to the percentage of 
full time work, which is defined as 40 hours per week. 
Sick leave and disability pension were categorised as none, part time or full 
time sick leave/disability pension, based on 40 hours of work per week. 
Medications. Use of analgesics/NSAID and psychotropics (meaning 
antidepressants and sedatives) was registered as positive when use was 
regular or as needed. 
Self-administered questionnaires 
The MFI-20. The instrument assesses five dimensions of fatigue: general 
fatigue, physical fatigue, mental fatigue, reduced motivation and reduced 
activity. It contains 20 statements on a five-point Likert scale that refer to 
aspects of fatigue experienced during the most recent days. The sum scores 
range from 4 to 20 for each subscale, and higher scores indicate a higher 
degree of fatigue (Furst & Ahsberg, 2001; Smets, et al., 1995).  
Fibromyalgia Impact Questionnaire (FIQ). The FIQ comprises ten subscales 
of disabilities and symptoms, ranging from 0 to 100 (Burckhardt, Clark, & 
Bennett, 1991), and it is validated for a Swedish FM population (Hedin, 
Hamne, Burckhardt, & Engstrom-Laurent, 1995). A higher score indicates 
lower health status. The total score, being the mean of the ten subscales, and 
the subscales for pain and fatigue were applied in the thesis. The patients 
estimated their pain intensity/how tired they had been during the previous 
week on a VAS, ranging from 0 to 100 mm (Burckhardt, et al., 1991). 
Pain localizations. The localization and distribution of pain were reported in 
a self-administered pain drawing with 18 predefined body regions, ranging 
from 0 to 18, referring to the number of body regions in pain (Bergman, 
2005). 
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Borg scale for rating perceived exertion (BRPE).The BRPE range from 6 to 
20 and was used to record exertion during pool exercise in Study III and 
Study IV (Borg, 1982). 
Manual examinations 
Tender points. Tender points were examined by manual palpation by trained 
physiotherapists (Wolfe, et al., 1990). 
Pain pressure threshold. Muscle tenderness was examined using a Somedic 
algometer (Somedic Production AB, Sollentuna, Sweden) (Kosek, Ekholm, 
& Hansson, 1996). 
Body Mass Index (BMI). The BMI was calculated as the patient's body 
weight divided by the square of his or her height. 
Performance-based tests 
Six-minute walk test (6MWT). The patient was instructed to walk as quickly 
as he or she could without running and the distance in metres covered in six 
minutes was used as a measure of walking capacity. The test has shown 
satisfactory test-retest reliability in a Swedish FM population (Mannerkorpi, 
Svantesson, Carlsson, & Ekdahl, 1999). 
Isobex, shoulder abduction force. The isometric force of shoulder abduction 
was measured in Newton in Study III with Isobex 3.0 (Medical Device 
Solution AG, Burgdorf, Switzerland) in the plane of scapula at 45° and 
shoulder elevation at 90°, in a standardized position. Subjects were seated on 
a chair with their feet supported by the floor. The dynamometer was placed 
on the floor and the band from the dynamometer was placed just proximally 
to the styloid process of the ulna (Leggin, Neuman, Iannotti, Williams, & 
Thompson, 1996) 
Steve Strong, Knee extension and flexion force. Isometric force in the knee 
extensors and flexors was measured in Study III. The patients were seated 
with the back supported, a seat belt around the waist, with both legs hanging 
freely. The knee angle was 90°. A non-elastic strap was placed around the 
ankle and attached to a pressure transducer with an amplifier (Steve Strong, 
Stig Starke HB, Gothenburg, Sweden). The subjects were instructed to pull 
the ankle strap maximally for three seconds in either knee extension or 
flexion. The best of three efforts was reported as the maximal isometric 
quadriceps/hamstrings force in Newton (Schaufelberger et al., 2001). 
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The Grippit, hand grip force. Hand grip force was measured as the sustained 
maximum voluntary contraction during ten seconds, measured in Newton 
using an electronic instrument, the Grippit (Nordenskiold & Grimby, 1993). 
4.3 Procedures 
4.3.1 Study I 
All 166 patients in the female population completed the FIQ fatigue and the 
MFI-20 and the correlations between the two instruments were calculated to 
investigate the convergent construct validity of the Swedish version of the 
MFI-20. 
The patients were also asked to complete the MFI-20 on two occasions, one 
day apart, so the test – retest reliability of the Swedish version of the MFI-20 
could be investigated. The data for the test-retest reliability study were 
collected six months after the validity study. 
Additional analyses Study I 
The Swedish version of the MFI-20 was analysed for convergent construct 
validity (n=44) and test-retest reliability (n=26) also in the male population, 
following the same procedure as described above for the female population. 
The internal consistency of the Swedish version of the MFI-20 was calculated 
separately for the female population (n=166) and the male population (n=44). 
4.3.2 Study II 
The data of the female population collected at baseline in Study III were used 
to investigate the usefulness of multiple fatigue dimensions in patients with 
FM. The subscales of the MFI-20 and the FIQ fatigue were compared by 
correlating the two fatigue instruments with socio-demographic and health 
related aspects as well as explanatory factors for severe fatigue. Variables 
shown to be associated with fatigue in previous research were chosen to be 
included in the analyses of correlations and explanatory factors (Kop, et al., 
2005; Kurtze & Svebak, 2001; Nicassio, et al., 2002; Rutledge, et al., 2007; 
Wolfe, et al., 1996). 
Fibromyalgia and chronic widespread pain. Dimensions of fatigue and effects of physiotherapy 
30 
Borg scale for rating perceived exertion (BRPE).The BRPE range from 6 to 
20 and was used to record exertion during pool exercise in Study III and 
Study IV (Borg, 1982). 
Manual examinations 
Tender points. Tender points were examined by manual palpation by trained 
physiotherapists (Wolfe, et al., 1990). 
Pain pressure threshold. Muscle tenderness was examined using a Somedic 
algometer (Somedic Production AB, Sollentuna, Sweden) (Kosek, Ekholm, 
& Hansson, 1996). 
Body Mass Index (BMI). The BMI was calculated as the patient's body 
weight divided by the square of his or her height. 
Performance-based tests 
Six-minute walk test (6MWT). The patient was instructed to walk as quickly 
as he or she could without running and the distance in metres covered in six 
minutes was used as a measure of walking capacity. The test has shown 
satisfactory test-retest reliability in a Swedish FM population (Mannerkorpi, 
Svantesson, Carlsson, & Ekdahl, 1999). 
Isobex, shoulder abduction force. The isometric force of shoulder abduction 
was measured in Newton in Study III with Isobex 3.0 (Medical Device 
Solution AG, Burgdorf, Switzerland) in the plane of scapula at 45° and 
shoulder elevation at 90°, in a standardized position. Subjects were seated on 
a chair with their feet supported by the floor. The dynamometer was placed 
on the floor and the band from the dynamometer was placed just proximally 
to the styloid process of the ulna (Leggin, Neuman, Iannotti, Williams, & 
Thompson, 1996) 
Steve Strong, Knee extension and flexion force. Isometric force in the knee 
extensors and flexors was measured in Study III. The patients were seated 
with the back supported, a seat belt around the waist, with both legs hanging 
freely. The knee angle was 90°. A non-elastic strap was placed around the 
ankle and attached to a pressure transducer with an amplifier (Steve Strong, 
Stig Starke HB, Gothenburg, Sweden). The subjects were instructed to pull 
the ankle strap maximally for three seconds in either knee extension or 
flexion. The best of three efforts was reported as the maximal isometric 
quadriceps/hamstrings force in Newton (Schaufelberger et al., 2001). 
Anna Ericsson 
31 
The Grippit, hand grip force. Hand grip force was measured as the sustained 
maximum voluntary contraction during ten seconds, measured in Newton 
using an electronic instrument, the Grippit (Nordenskiold & Grimby, 1993). 
4.3 Procedures 
4.3.1 Study I 
All 166 patients in the female population completed the FIQ fatigue and the 
MFI-20 and the correlations between the two instruments were calculated to 
investigate the convergent construct validity of the Swedish version of the 
MFI-20. 
The patients were also asked to complete the MFI-20 on two occasions, one 
day apart, so the test – retest reliability of the Swedish version of the MFI-20 
could be investigated. The data for the test-retest reliability study were 
collected six months after the validity study. 
Additional analyses Study I 
The Swedish version of the MFI-20 was analysed for convergent construct 
validity (n=44) and test-retest reliability (n=26) also in the male population, 
following the same procedure as described above for the female population. 
The internal consistency of the Swedish version of the MFI-20 was calculated 
separately for the female population (n=166) and the male population (n=44). 
4.3.2 Study II 
The data of the female population collected at baseline in Study III were used 
to investigate the usefulness of multiple fatigue dimensions in patients with 
FM. The subscales of the MFI-20 and the FIQ fatigue were compared by 
correlating the two fatigue instruments with socio-demographic and health 
related aspects as well as explanatory factors for severe fatigue. Variables 
shown to be associated with fatigue in previous research were chosen to be 
included in the analyses of correlations and explanatory factors (Kop, et al., 
2005; Kurtze & Svebak, 2001; Nicassio, et al., 2002; Rutledge, et al., 2007; 
Wolfe, et al., 1996). 
Fibromyalgia and chronic widespread pain. Dimensions of fatigue and effects of physiotherapy 
32 
4.3.3 Study III 
Outcomes 
Primary outcomes in study III were the FIQ total and the 6MWT. Secondary 
outcomes were the FIQ Pain, the FIQ fatigue, the SF-36, the HADS and the 
LTPAI. Exploratory outcomes were the SCI-93, the MFI-20 and Experience 
of physical activity. 
Examinations 
The trained examiners were blinded to the patients’ group assignments. The 
examination for the ACR criteria for FM and CWP  (Wolfe, et al., 1990) 
included a pain localization sheet (Bergman, 2005), a standardized interview 
and an examination of tender points (Wolfe, et al., 1990). The patients 
completed a battery of questionnaires and performed the 6MWT. The FIQ, 
the SF36, the HADS, the LTPAI and the SCI-93 were completed at baseline, 
post-test (20 weeks after baseline) and follow-up (11-12 months after 
baseline). The MFI-20 and the Experience of Physical Activity scale were 
completed at baseline and post-test. The patients were instructed to continue 
their baseline medical treatment with no change throughout the 20-week 
study period, and their medical treatment was monitored at post-test. 
Interventions 
The education programme, which was designed to introduce strategies to 
cope with the FM symptoms, consisted of six one-hour sessions, conducted 
once a week for six weeks. The programme was led by a physiotherapist. The 
pedagogical approach was based on the active participation of the patients 
through discussions and practical exercises. The topics were theories for 
long-lasting pain, pain alleviation, physical activity, stress, relaxation and 
modifications of lifestyle to enhance health. At each session, the patients 
drew up a plan (a contract) for physical activity for the next week and 
performed a short relaxation exercise. The control group received the same 
education programme. Details of the programme are shown in paper III, 
Appendix I. 
The exercise programme comprised 20 sessions of 45-min pool exercise once 
a week for 20 weeks in temperate (33°C) water, supervised by a 
physiotherapist. The exercise was planned to permit individual progress, 
aiming to improve overall function and to motivate regular physical activity. 
The median value for exertion (6–20), measured by the BRPE (Borg, 1982), 
ranged from 9 (“very light”) to 11 (“fairly light”) during flexibility, co-
ordination and stretching exercises, while it was 13 (“somewhat hard”) 
during aerobic exercise (Garber, et al., 2011). Heart rate (HR) was monitored 
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with a Polar S610i HR monitor (Kempele, Finland) and expressed in values 
for age-adjusted maximum HR, 220 minus age (HRmax). The mean value for 
HR during the programme ranged from 48% to 65% HRmax, which 
corresponds to very light to moderate intensity (Garber, et al., 2011). Details 
of the programme are shown in paper III, Appendix II.  
Outcomes in Study III were evaluated using both an intention to treat (ITT) 
and a per-protocol design, which was defined as attendance at least 60 % of 
the sessions. 
4.3.4 Study IV 
Primary outcomes in study IV were the MFI-20. Secondary outcomes were 
the HADS, isometric force in shoulder abduction (Isobex), isometric force in 
knee extension and flexion (Steve Strong) and hand grip force (Grippit). 
Exploratory outcomes were the FIQ Pain, number of pain localizations, the 
SF-36 PCS and the SF-36 MCS. 
Examinations  
The trained examiners were blinded to the patients´ group assignments in the 
randomized trial. The examination for the ACR criteria for CWP and FM 
(Wolfe, et al., 1990) included the pain localization sheet (Bergman, 2005), a 
standardized interview and an examination of tender points (Wolfe, et al., 
1990). The patients in the randomized trial and in the reference group 
completed a battery of questionnaires and the performance-based tests (Table 
2) at baseline and 12 weeks after baseline. The patients in the randomized 
trial also performed the tests nine months after baseline. All patients were 
instructed not to change their baseline medical treatment throughout the 12-
week study period, and their medical treatment was monitored at the 12-week 
examination. 
Interventions 
The pool exercise programme comprised 50-minute sessions in groups of six 
to eight patients twice a week for a period of 12 weeks in temperate (33°C) 
water, supervised by a physical therapist. The session included aerobic 
exercise for endurance, strength, flexibility, coordination and relaxation. The 
patients were instructed to exercise at their own rhythm and to modify the 
exercises individually with respect to thresholds of pain and fatigue. During 
the 12-week study period, they were encouraged to increase intensity and 
resistance with or without water equipment. The intensity during the pool 
exercise session was assessed with rate of perceived exertion on the BRPE 
(Borg, 1982) on two occasions in weeks 8 and 11.   
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The resistance training programme was followed twice a week for 12 weeks 
with free weights and resistance machines in groups of about eight to ten 
patients, supervised by a physical therapist. The session lasted for about one 
hour and included exercise for all four extremities, back and trunk, using 
dynamic exercises with excentric, concentric and isometric muscle actions 
(Ratamess, et al., 2009). A standardized protocol for resistance progress was 
applied (Hakkinen, Hakkinen, Hannonen, & Alen, 2001; Ratamess, et al., 
2009; Valkeinen et al., 2005). During the 12-week study period, the load was 
planned to be increased individually from approximately 40 % to 80 % of one 
repetition maximum (RM) established at baseline. One RM is defined as “the 
heaviest resistance that can be used for one complete repetition of an 
exercise”(Fleck & Kraemer, 2004). At week 1, the patients performed three 
sets with 15-20 repetitions of each exercise. When the load increased, they 
still performed three sets but with fewer repetitions. All sessions started with 
ten minutes of warm-up on an ergometer bicycle. 
4.4 Statistical analyses 
An overview of the statistical tests used in the thesis is shown in Table 3. All 
the tests were two-tailed and conducted at the 5% significance level 
Descriptive statistics are presented as mean, standard deviation (SD) and 
range for continuous variables and as number and percent for categorical 
variables.  
The Spearman’s correlation coefficient was used in Study I to calculate 
convergent construct validity and in Study II to calculate correlations 
between fatigue and other variables. The following classification was used to 
interpret the correlation values: correlations from 0 to 0.25 indicate little or 
no relationship, those from 0.25 to 0.50 indicate a fair degree of relationship, 
those from 0.50 to 0.75 a moderate to good relationship, while a correlation 
above 0.75 indicates a very good to excellent relationship (Colton, 1974).   
Intra Class Correlation, Limits of Agreement and Intra-individual standard 
deviation (SD). The test-retest reliability of the MFI-20 was calculated in 
Study I using the intraclass correlation coefficient (ICC) with 95% 
confidence intervals (Shrout & Fleiss, 1979) as well as the mean, SD and 
range of the differences between the readings (test 2 - test 1), the limits of 
agreement (J. M. Bland & Altman, 1986) and the intra-individual SD (J.M. 
Bland & Altman, 1996). The limits of agreement provide a range within 
which 95% of all the differences between test 2 and test 1 are found (J. M. 
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Bland & Altman, 1986).  Wilcoxon’s Signed rank test was used to analyse 
systematic differences in the variables between test 1 and test 2.  
The following classification was used to interpret the ICC values in Study I: 
correlation values below 0.40 represent poor reliability, values from 0.40 to 
0.75 indicate fair to good reliability and values above 0.75 may be taken to 
represent excellent reliability (Fleiss, 1986).  
Cronbach´s alpha As an additional analysis to Study I in the present thesis, 
Cronbach´s alpha was calculated for the five subscales of the MFI-20 to 
investigate internal consistency. Cronbach´s alpha coefficients above 0.7 are 
considered acceptable but values above 0.8 are preferable (Pallant, 2010). 
Logistic regression. Explanatory factors of severe fatigue in Study II were 
analysed using logistic regression (Altman, 1999). As there is no known cut-
off score for any of the five continuous MFI-20 subscales or for FIQ fatigue 
indicating more or less severe fatigue in an FM population, the cut off value 
for severe fatigue was defined as the median value of the patients´ scorings. 
The variables that showed a statistically significant association with MFI-20 
and/or FIQ fatigue in the Spearman´s correlation analyses were included in 
the univariate logistic regression. The statistically significant explanatory 
factors (p<0.05 ) of the dichotomised subscales of the MFI-20 and FIQ 
fatigue in the univariate logistic regression analysis were included in the 
stepwise multivariate procedure, where a set of independent predictors of 
explanatory factors was selected for each of the six outcome variables. Odds 
ratios (OR) with 95% confidence intervals and p-value are presented. 
The AUC values (the area under the Receiver Operating Characteristic 
(ROC) curve) were calculated in Study II for description of goodness of 
explanatory factors (Hanley & McNeil, 1982). 0.7≤AUC < 0.8 indicates that 
the explanatory variables are acceptable, 0.8 ≤AUC < 0.9 indicates that they 
are excellent and AUC ≥0.9 indicates that they are outstanding (Hosmer & 
Lemeshow, 2000). 
In Study II and the additional analyses of between-group differences in 
fatigue, logistic regression with group as dependent variable and the FIQ 
fatigue, the MFI-20 subscales and the covariates as independent variables 
was used to analyse differences in fatigue scales between the two groups 
adjusted for the covariates. 
Between-group comparisons. For comparisons between two groups in Study 
II, III and IV and in the additional analyses, the Mann Whitney U-test was 
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used for continuous variables, Fisher´s exact test for dichotomous variables 
and Mantel- Haenszel chi-square test for ordinal categorical variables. 
Within-group comparisons. For comparisons within groups in Study IV, p-
values for change over time were calculated. McNemar´s test was used for 
change over time in dichotomous variables and Wilcoxon´s Signed rank test 
was used for change over time in continuous variables. 
Effect size was calculated in study III for variables showing a significant 
change. Effect size for between-group analyses was calculated by dividing 
the mean difference between the post-test score and baseline score in the 
exercise-education group and in the education group by the pooled SD. Effect 
size for the 11–12 months follow-up was calculated as the mean difference 
between the follow-up score and baseline score divided by the SD at baseline. 
Effect sizes from 0.20 to < 0.50 were regarded as small, while effect sizes 
from 0.50 to < 0.80 were regarded as moderate (Fayers & Machin, 2001).  
Upper limit of expected number of false significances. To control Type I 
errors, the upper limit of expected number of false significances for the 
secondary and exploratory variables was calculated in Study III and IV by the 
following formula: α/1– α × number of tests – number of significant tests on 
the significance level α). 
Sub-group analysis. Pre-specified subgroups were created in study III by 
dichotomized values for the SCI-93, the FIQ Pain, the HADS-D and the SF-
36 physical functioning. The SCI-93, the FIQ Pain and the SF-36 physical 
functioning were dichotomized by the median value, as there are no known 
cut-off points for these variables indicating more or less pathology in a pain 
population, while the HADS-D was dichotomized by a score of 8, which 
indicates possible depression (Herrmann, 1997). The heterogeneity, an 
interaction between the independent variable, group membership and the 
change score for the primary outcome measure (the FIQ total and the 
6MWT), was analysed using a generalized linear model for subgroup 
analyses. A significant heterogeneity implies different effects of the 
intervention for 2 subgroups. Differences in the change scores were analysed 
by Fisher’s non-parametric permutation test, and mean differences with 95% 
confidence intervals within each subgroup are presented in the graph (Figure 
  
7). 
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Table 3. Overview of statistical tests in the thesis 
Statistical test Study I 
Study 
II 
Study 
III 
Study 
IV 
Descriptive statistics X X X X 
Spearman´s correlation coefficent X X   
Intra Class Correlation coefficient X    
Intra-Individual standard deviation X    
Limits of agreement X    
Wilcoxon´s Signed rank test X  X X 
Cronbach´s alpha* X    
Mann-Whitney U-test.  X X X 
Fisher’s exact test  .  X X X 
Mantel Haenszel Chi-2 test  X X X 
McNemar´s test   X X 
Logistic regression  X   
Effect size   X  
Fisher’s non-parametric permutation test   X  
Upper limit of expected number of false 
significances   X X 
*Additional analysis in the present thesis, not included in paper I. 
 
4.5 Ethical considerations 
Ethical approval was granted for all four studies in the present thesis by the 
Regional Ethical Review Board in Gothenburg, Sweden. Written informed 
consent was obtained from all patients. 
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6). 
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5 RESULTS 
The present thesis will be available electronically. Papers II and IV have not 
yet been published. To avoid compromising future publications, the results of 
Studies II and IV will only be presented briefly in the following results 
section. 
5.1 Group characteristics 
Group characteristics are given in Table 4 for the female population and 
Table 5 for the male population. The age for the whole female population 
ranged from 22 to 60 years, mean 45.6 (SD 8.8). The age for the whole male 
population ranged from 26 to 59 years, mean 49 (SD 8.7). 
The patients with FM had significantly more tender points and self-rated pain 
localizations and worked significantly less hours per week than the patients 
with CWP, in both the female and the male population.  
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Table 4. Socio-demographic data of the female population (n=166: 134 
FM, 32 CWP). 
 FM&CWP FM CWP FM vs 
n=166 n=134 n=32 CWP 
Mean(SD) Mean(SD) Mean(SD) p-value 
Age [years]  45.6 (8.8) 45.6 (8.6) 45.5 (9.8) 0.905 
Symptom duration [years] 10.5 (7.1) 10.7 (7.2) 9.5 (7.0) 0.340 
Tender points [n] 13.5 (3.5) 14.8 (2.4) 8.1 (2.1) <0.001 
Pain localization [0-18] 12.9 (3.4) 13.4 (3.3) 10.9 (3.2) <0.001 
 n (%) n (%) n (%)  
Living with an adult 123 (74) 104 (78) 19 (59) 0.044 
Born outside Sweden 27 (16) 22 (16) 5 (16) 1.000 
Education     
     ≤9 years 38 (23) 30 (22)  8 (25)  
     10-12 years 89 (54) 71 (53) 18 (56) 0.563 
     >12 years 38 (23) 32 (24) 6 (19)  
Employment     
     0 % 98 (59) 83 (62) 15 (47) 
0.044     1-49  % 14 (9) 13 (10) 1 (3) 
    50-79 % 37 (22) 26 (19) 11 (34) 
     80-100 % 17 (10) 12 (9) 5 (16) 
Sick leave     
    None  87 (52) 68 (51) 18 (56) 
0.546     Part time 31 (19) 26 (19) 6 (19) 
    Full time 48 (29) 40 (30) 8 (25) 
Disability pension     
    None 100 (60) 78 (58) 22 (69) 
0.451     Part time 29 (18) 26 (19) 3 (9) 
    Full time 37 (22) 30 (22) 7 (22) 
Pharmacological treatment     
    Analgesics 118 (29) 93 (69) 25 (78) 0.391 
    Psychotropic drugs* 74 (45) 59 (44) 15 (47) 0.844 
*Antidepressants, sedatives 
SD = Standard deviation 
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     10-12 years 89 (54) 71 (53) 18 (56) 0.563 
     >12 years 38 (23) 32 (24) 6 (19)  
Employment     
     0 % 98 (59) 83 (62) 15 (47) 
0.044     1-49  % 14 (9) 13 (10) 1 (3) 
    50-79 % 37 (22) 26 (19) 11 (34) 
     80-100 % 17 (10) 12 (9) 5 (16) 
Sick leave     
    None  87 (52) 68 (51) 18 (56) 
0.546     Part time 31 (19) 26 (19) 6 (19) 
    Full time 48 (29) 40 (30) 8 (25) 
Disability pension     
    None 100 (60) 78 (58) 22 (69) 
0.451     Part time 29 (18) 26 (19) 3 (9) 
    Full time 37 (22) 30 (22) 7 (22) 
Pharmacological treatment     
    Analgesics 118 (29) 93 (69) 25 (78) 0.391 
    Psychotropic drugs* 74 (45) 59 (44) 15 (47) 0.844 
*Antidepressants, sedatives 
SD = Standard deviation 
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Table 5. Socio-demographic data of the male population (n=44:  6 FM, 
38 CWP). 
 FM&CWP FM CWP FM vs 
n=44 n=6 n=38 CWP 
Mean(SD) Mean(SD Mean(SD p-value 
Age [years]  49.3 (8.7) 53.7 (4.0) 48.6 (9.0) 0.288 
Symptom duration [years] 6.1 (4.2) 6.8 (2.9) 6.0 (4.5) 0.269 
Tender points [n] 6.7 (4.1) 14 (2.4) 5.6 (3.0) <0.001 
Pain localization [0-18] 9.5 (3.4) 13.8 (3.7) 8.8 (2.9) 0.004 
 n (%) n (%) n (%)  
Living with an adult 35 (80) 3 (50) 32 (84) 0.089 
Born outside Sweden 8 (18) 1 (17) 7 (18) 1.000 
Education     
     ≤9 years 17 (39) 4 (67) 13 (34) 
0.079      10-12 years 16 (36) 2 (33) 14 (37) 
     >12 years 11 (25) 0 (0) 11 (29) 
Employment     
     0 % 9 (20) 3 (50) 6 (16) 
0.029     1-49  % 2 (5) 0 (0) 2 (5) 
    50-79 % 5 (11) 2 (33) 3 (8) 
     80-100 % 28 (64) 1 (17) 27 (71) 
Sick leave     
    None  41 (93) 5 (83) 36 (94)  
    Part time 2 (5) 1 (17) 1 (3) 0.581 
    Full time 1 (2) 0 (0) 1 (3)  
Disability pension     
    None 33 (75) 2 (33) 31 (82) 
0.025     Part time 5 (11) 2 (33) 3 (8) 
    Full time 6 (14) 2 (33) 4 (10) 
Pharmacological treatment     
    Analgesics 25 (57) 4 (67) 21 (55) 0.058 
    Psychotropic drugs* 10 (23) 3 (50) 7 (18)  
*Antidepressants, sedatives 
SD = Standard deviation 
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5.2 Validity and reliability of the Swedish 
version of the MFI-20 
5.2.1 Convergent construct validity 
Female population 
Spearman’s correlation coefficient revealed a significant association between 
all five subscales of the MFI-20 and the FIQ fatigue in the female population. 
The correlation values ranged from 0.32 for MFI reduced motivation to 0.62 
for MFI general fatigue (Table 6). 
Male population 
Additional analyses (not included in papers I to IV) of convergent construct 
validity were made for the male population (n=44). Significant associations 
were found between all five subscales of the MFI-20 and the FIQ fatigue in 
the male population. The correlation values ranged from 0.55 for MFI 
reduced motivation to 0.78 for MFI general fatigue (Table 6). 
 
Table 6. Spearman’s correlation coefficients (rs) between the five 
subscales of the Multidimensional Fatigue Inventory (MFI-20) and FIQ 
fatigue for the female population (n=165) and the male population 
(n=44). 
  FIQ fatigue 
 Female population Male population 
 rs p-value rs p-value 
General Fatigue 0.62 <0.001 0.78 < 0.001 
Physical Fatigue  0.36 <0.001 0.58 < 0.001 
Mental Fatigue  0.37 <0.001 0.57 < 0.001 
Reduced Motivation 0.32  <0.001 0.55 < 0.001 
Reduced Activity 0.36  <0.001 0.58 < 0.001 
FIQ=Fibromyalgia Impact Questionnaire 
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5.2.2 Test-retest reliability 
Female population 
The scores of the 36 women on the MFI-20 at test 1 and test 2 are presented 
in Table 7. The mean interval between test 1 and test 2 of the MFI-20 was 
1.06 days (SD 0.3).  
The ICC values for the MFI-20 in the 36 women are given in Table 8. All 
five subscales showed relatively high ICC values, ranging from 0.75 for MFI 
physical fatigue to 0.92 for MFI mental fatigue. The mean, SD and range of 
the differences, the limits of agreement and the intra-individual SD in the 36 
women are presented in Table 9. All the subscales had low means of the 
differences, around zero. 
A systematic difference was found for MFI mental fatigue (p=0.03), showing 
that the patients’ levels of mental fatigue were slightly lower at the second 
occasion (test 2). Figure 3 in paper I shows how the differences between test 
1 and test 2 vary over the range of measurement (J. M. Bland & Altman, 
1986). 
 
Table 7. The scores of the Multidimensional Fatigue Inventory at test 1 
and test 2, in 36 women with FM or CWP. 
 Test 1 Test 2 
 mean (SD) range mean (SD) range 
General Fatigue 16.0 (3.2) 6 – 20 15.9 (3.8) 4 – 20 
Physical Fatigue  15.9 (3.6) 5 – 20 15.3 (3.7) 6 – 20 
Mental Fatigue  14.4 (4.3) 4 – 20 13.8 (4.1)  4 – 20 
Reduced Motivation  9.9 (3.8) 4 – 20 9.7 (4.0)  4 – 20  
Reduced Activity  14.1 (3.8) 7 – 20  14.3 (3.8) 7 – 20  
SD=Standard deviation 
 
Table 8. The Multidimensional Fatigue Inventory. The Intra class 
Correlation Coefficients (ICC) and 95 % confidence intervals (CI) for the 
ICC in 36 women with FM or CWP. 
  ICC 95 % C.I. 
General Fatigue  0.88 0.78 - 0.94  
Physical Fatigue  0.75 0.56 - 0.86 
Mental Fatigue  0.92 0.85 - 0.96 
Reduced Motivation 0.86 0.75 - 0.93 
Reduced Activity  0.89 0.79 - 0.94 
Anna Ericsson 
43 
 
Table 9.  The Multidimensional Fatigue Inventory. The mean, standard 
deviation (SD) and range of the differences (test 2 – test 1), the limits of 
agreement (LOA) and the intra-individual standard deviations (IISD) in 
36 women with FM or CWP. 
  
Difference 
mean (SD) 
Difference 
min-max LOA IISD 
General Fatigue  -0.1 (1.7) -5.0 – 3.0 -3.5 – 3.3 1.2 
Physical Fatigue  -0.6 (2.6) -8.0 – 6.0 -5,7 – 4,5 1.9 
Mental Fatigue  -0.7 (1.7) -7.0 – 1.0 -4,0 – 2,7 1.3 
Reduced Motivation -0.2 (2.0) -7.0 – 3.0 -4.2 – 3,9 1.4 
Reduced Activity   0.1 (1.8) -5.0 – 5.0 -3,4 – 3,6 1.3 
Male population 
Additional analyses (not included in papers I to IV) of test-retest reliability of 
the Swedish version of the MFI-20 were made for 26 patients in the male 
population. The scorings of the 26 men on the MFI-20 at test 1 and test 2 are 
presented in Table 10. The mean interval between test 1 and test 2 of the 
MFI-20 was 1.12 days (SD 0.4).  
The ICC values for the MFI-20 in the 26 men are given in Table 11. All five 
subscales showed high ICC values, ranging from 0.83 for MFI reduced 
motivation to 0.94 for MFI physical fatigue. The mean and standard 
deviation (SD) of the differences, the limits of agreement and the intra-
individual SD in the 26 men are presented in Table 12. All the subscales had 
low means of the differences, around zero. 
No systematic differences were found between test 1 and test 2 for any of the 
fatigue measures. 
 
Table 10. The scores of the Multidimensional Fatigue Inventory test 1 
and test 2, in 26 men with FM or CWP. 
 Test 1 Test 2 
 mean (SD) Range mean (SD) Range 
General Fatigue 14.1 (3.9) 5 – 20 14.1 (4.9) 4 – 20 
Physical Fatigue  13.7 (4.3) 5 – 20 13.4 (4.7) 4 – 20 
Mental Fatigue  10.4 (3.8) 4 – 17 10.2 (3.9) 4 – 16 
Reduced Motivation  8.6 (3.2) 4 – 16 9.2 (3.2) 4 – 15 
Reduced Activity  12.1 (4.3) 4 – 20 12.1 (4.2) 4 – 20 
SD=Standard deviation 
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Table 11. The Multidimensional Fatigue Inventory. The Intra class 
Correlation Coefficients (ICC) and 95 % confidence intervals (CI) for the 
ICC in 26 men with FM or CWP. 
  ICC 95 % C.I. 
General Fatigue  0.91 0.80-0.96 
Physical Fatigue  0.94 0.87-0.97 
Mental Fatigue  0.84 0.66-0.93 
Reduced Motivation 0.83 0.63-0.92 
Reduced Activity  0.88 0.74-0.94 
 
Table 12. The Multidimensional Fatigue Inventory. The mean, standard 
deviation (SD) and range of the differences (test 2 – test 1), the limits of 
agreement (LOA) and the intra-individual standard deviation (IISD) in 
26 men with FM or CWP. 
  
Difference 
mean (SD) 
Difference 
min-max LOA IISD 
General Fatigue  -0.1 (1.9) -4.0 – 5.0 -3.9 – 3.6 1.3 
Physical Fatigue  -0.2 (1.6) -4.0 – 3.0 -3.3 – 2.8 1.1 
Mental Fatigue  -0.3 (2.2) -7.0 – 4.0 -4.6 – 4.0 1.5 
Reduced Motivation  0.3 (2.0) -3.0 – 4.0 -3.6 – 4.3 1.4 
Reduced Activity -0.1 (2.0) -4.0 – 4.0 -3.9 – 3.8 1.4 
 
5.2.3 Internal consistency 
Additional analyses (not included in papers I to IV) were made in the present 
thesis to investigate the internal consistency of the Swedish version of the 
MFI-20. Cronbach´s alpha values for the five subscales of the MFI-20 are 
given in Table 13, for both the female and the male population. 
In the female population, the Cronbach´s alpha values ranged from 0.65 for 
MFI reduced motivation to 0.82 for MFI mental fatigue and MFI reduced 
activity. In the male population, the Cronbach´s alpha values ranged from 
0.65 for MFI reduced motivation to 0.89 for MFI reduced activity. 
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Table 13. Cronbach´s alpha for the five subscales of the Swedish version 
of the Multidimensional Fatigue Inventory in the female population 
(n=166) and the male population (n=44). 
  Cronbach´s alpha 
 Female population Male population 
General Fatigue 0.68 0.81 
Physical Fatigue  0.78 0.86 
Mental Fatigue  0.82 0.83 
Reduced Motivation 0.65 0.65 
Reduced Activity 0.82 0.89 
 
 
5.3 Usefulness of the MFI-20 
133 patients with FM (mean age 46 years, SD: 8.6, range: 22-60) from the 
female population participated in the study of the contexts in which MFI-20 
is useful in FM. The socio-demographic data of the female patients with FM 
are shown in Table 4 and descriptive statistics of the health related aspects for 
the patient group are given in paper II, Table 2. 
5.3.1 Associations with fatigue in FM 
Socio-demographic aspects  
Age and education showed no association with fatigue. Employment showed 
a fairly negative correlation to MFI physical fatigue and MFI reduced 
activity, indicating that these two fatigue dimensions were associated with 
fewer work hours per week. Employment was not associated with FIQ 
fatigue (paper II, Table 4).  
In the analyses of differences in fatigue between the two groups of marital 
status, no statistically significant differences were found for the MFI-20, but 
FM patients living with another adult reported less FIQ fatigue than those 
who did not cohabit (p=0.01). No statistically significant differences were 
found between smoking and non-smoking patients with FM for the MFI-20 
or FIQ fatigue scores. 
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Health related aspects  
FIQ fatigue and nearly all dimensions of the MFI-20 showed fair to moderate 
correlations with depression (HADS-D) and anxiety (HADS-A). MFI general 
fatigue and FIQ fatigue also showed a fair correlation to sleep quantity and 
sleep quality. FIQ pain showed a fair correlation to MFI general fatigue, MFI 
physical fatigue and FIQ fatigue. Number of tender points, pain localizations 
and BMI were not associated with any of the fatigue measures (paper II, 
Table 4). 
Physical activity (LTPAI) showed a fairly negative correlation with MFI 
reduced activity. Walking capacity (6MWT) showed fairly negative 
correlations to MFI physical fatigue and MFI reduced activity. FIQ fatigue 
was not associated with physical activity or walking capacity (paper II, Table 
4). 
5.3.2 Explanatory factors of severe fatigue in FM 
Cut-off values. The following cut-off values between fatigue and severe 
fatigue were based on the median of the patients´ scorings:  MFI general 
fatigue >18 vs ≤18, MFI physical fatigue >18 vs ≤18, MFI mental fatigue 
>15 vs ≤15,MFI reduced motivation >10 vs ≤10, MFI reduced activity >16 vs 
≤16 and FIQ fatigue >85 vs ≤85. Independent explanatory factors for MFI-20 
and FIQ fatigue from univariate analyses are given in paper II, Table 5, and 
multivariate analyses in paper II, Table 6.  
MFI general fatigue. The multivariate stepwise logistic regression showed 
that depression (HADS-D) (p<0.001) and sleep quality (p<0.001) contributed 
to the strongest model for explanatory factors for severe general fatigue 
(AUC=0.77) (paper II, Table 6) 
MFI physical fatigue. FIQ pain (p<0.001) alone contributed to the strongest 
model for explanatory factors of severe physical fatigue (AUC=0.70). An 
alternative model could be created with the same AUC value (0.70), in which 
the variables of employment (p=0.020) and depression (HADS-D) (p=0.009) 
explained severe physical fatigue (paper II, Table 6). 
MFI  mental fatigue. Depression (HADS-D) (p=0.005) and anxiety (HADS-
A) (p=0.019) contributed to the strongest model for explanatory factors for 
severe mental fatigue (AUC=0.78) (paper II, Table 6). 
MFI reduced motivation. Depression (HADS-D) (p<0.001) alone contributed 
to the strongest model for explanatory factors for severely reduced 
motivation (AUC=0.80) (paper II, Table 6). 
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MFI reduced activity. Age (p=0.003), employment (p=0.028), depression 
(HADS-D) (p<0.0001) and physical activity (LTPAI) (p=0.005) contributed 
to the strongest model when predicting severely reduced activity (AUC=0.82) 
(paper II, Table 6). 
FIQ fatigue. FIQ pain (p=0.027), sleep quality (p=0.043) and depression 
(HADS-D) (0.003) contributed to the strongest model for explanatory factors 
for severe FIQ fatigue (AUC=0.77). An alternative model was able to be 
created with the same AUC value (0.77), in which anxiety (HADS-A) (p= 
0.003) together with FIQ pain (p=0.010) and sleep quality (p=0.024) 
explained severe FIQ fatigue (paper II, Table 6). 
 
5.4 Dimensions of fatigue in FM and CWP 
Female population 
The scores of the MFI-20 and the FIQ fatigue for the whole female 
population (n=166) as well as separately for FM and CWP are given in Table 
14. There were no significant differences in scores on MFI-20 and FIQ 
fatigue between the women with FM (n=134) and the women with CWP. 
 
Table 14. The female population (n=166). Mean, standard deviation (SD) 
and range for the five subscales of the Multidimensional Fatigue 
Inventory (MFI-20) and the subscale for fatigue included in the 
Fibromyalgia Impact Questionnaire (FIQ), as well as p-values for the 
difference between FM and CWP. 
 FM & CWP 
n=166 
FM 
n=134 
CWP 
n=32 
FM vs 
CWP 
 mean(SD) range mean(SD) range mean(SD) range p-value 
GF 17.4 (2.7) 9-20 17.5 (2.7) 9-20 16.8 (2.7) 12-20 0.123 
PF 17.1 (2.8) 9-20 17.2 (2.8) 9-20 16.6 (2.7) 10-20 0.137 
MF 14.3 (4.0) 4-20 14.5 (4.0) 4-20 13.3 (4.1) 4-20 0.136 
RM 10.5 (3.8) 4-20 10.4 (3.9) 4-20 11.0 (3.6 ) 4-18 0.409 
RA 15.5 (3.4) 7-20 15.7 (3.5) 7-20 14.6 (3.1) 7-20 0.092 
FIQ fat 79.1 (20) 15-100 80.0 (20) 15-100 74.1 (20) 42-100 0.076 
GF= general fatigue, PF= physical fatigue, MF=mental fatigue, RM= reduced 
motivation, RA=reduced activity, FIQ fat= FIQ fatigue 
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Health related aspects  
FIQ fatigue and nearly all dimensions of the MFI-20 showed fair to moderate 
correlations with depression (HADS-D) and anxiety (HADS-A). MFI general 
fatigue and FIQ fatigue also showed a fair correlation to sleep quantity and 
sleep quality. FIQ pain showed a fair correlation to MFI general fatigue, MFI 
physical fatigue and FIQ fatigue. Number of tender points, pain localizations 
and BMI were not associated with any of the fatigue measures (paper II, 
Table 4). 
Physical activity (LTPAI) showed a fairly negative correlation with MFI 
reduced activity. Walking capacity (6MWT) showed fairly negative 
correlations to MFI physical fatigue and MFI reduced activity. FIQ fatigue 
was not associated with physical activity or walking capacity (paper II, Table 
4). 
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fatigue were based on the median of the patients´ scorings:  MFI general 
fatigue >18 vs ≤18, MFI physical fatigue >18 vs ≤18, MFI mental fatigue 
>15 vs ≤15,MFI reduced motivation >10 vs ≤10, MFI reduced activity >16 vs 
≤16 and FIQ fatigue >85 vs ≤85. Independent explanatory factors for MFI-20 
and FIQ fatigue from univariate analyses are given in paper II, Table 5, and 
multivariate analyses in paper II, Table 6.  
MFI general fatigue. The multivariate stepwise logistic regression showed 
that depression (HADS-D) (p<0.001) and sleep quality (p<0.001) contributed 
to the strongest model for explanatory factors for severe general fatigue 
(AUC=0.77) (paper II, Table 6) 
MFI physical fatigue. FIQ pain (p<0.001) alone contributed to the strongest 
model for explanatory factors of severe physical fatigue (AUC=0.70). An 
alternative model could be created with the same AUC value (0.70), in which 
the variables of employment (p=0.020) and depression (HADS-D) (p=0.009) 
explained severe physical fatigue (paper II, Table 6). 
MFI  mental fatigue. Depression (HADS-D) (p=0.005) and anxiety (HADS-
A) (p=0.019) contributed to the strongest model for explanatory factors for 
severe mental fatigue (AUC=0.78) (paper II, Table 6). 
MFI reduced motivation. Depression (HADS-D) (p<0.001) alone contributed 
to the strongest model for explanatory factors for severely reduced 
motivation (AUC=0.80) (paper II, Table 6). 
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MFI reduced activity. Age (p=0.003), employment (p=0.028), depression 
(HADS-D) (p<0.0001) and physical activity (LTPAI) (p=0.005) contributed 
to the strongest model when predicting severely reduced activity (AUC=0.82) 
(paper II, Table 6). 
FIQ fatigue. FIQ pain (p=0.027), sleep quality (p=0.043) and depression 
(HADS-D) (0.003) contributed to the strongest model for explanatory factors 
for severe FIQ fatigue (AUC=0.77). An alternative model was able to be 
created with the same AUC value (0.77), in which anxiety (HADS-A) (p= 
0.003) together with FIQ pain (p=0.010) and sleep quality (p=0.024) 
explained severe FIQ fatigue (paper II, Table 6). 
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The scorings of 133 women with FM were compared with the scorings of the 
reference group of 158 healthy women. The socio-demographic data of the 
patients (n=133) and the reference group (n=158) are given in paper II, Table 
1. There were no significant differences between the patient group and the 
reference group in age, marital status, smoking or being born outside 
Sweden. There were significant differences between the groups (p<0.001) in 
education, employment, sick leave, disability pension and use of medication.  
The mean scores in the MFI-20 in the healthy reference group ranged from 
7.8 (SD 3.0) for MFI reduced motivation to 10.7 (SD 4.1) for MFI general 
fatigue. The female patients with FM showed statistically significantly 
(p<0.001) higher fatigue levels than the healthy women in all five dimensions 
of the MFI-20 and FIQ fatigue. Logistic regression showed that the 
differences in fatigue between the groups were also significant when adjusted 
for education, employment, sick leave and disability pension (paper II, Table 
3). 
Male population 
The scores of the MFI-20 and the FIQ fatigue in the whole male population 
(n=44) as well as separately for FM and CWP are given in Table 15. 
Significant differences were found between men with FM (n=6) and men 
with CWP (n=38) for MFI general fatigue and FIQ fatigue. 
Table 15. The male population (n=44). Mean, standard deviation (SD) 
and range for the five subscales of the Multidimensional Fatigue 
Inventory (MFI-20) and the subscale for fatigue included in the 
Fibromyalgia Impact Questionnaire (FIQ) and  p-values for the 
difference between FM and CWP. 
 FM & CWP 
n=44 
FM 
n=6 
CWP 
n=38 
FM vs 
CWP 
 mean(SD) range mean(SD) range mean(SD) range p-value 
GF 15.2 (3.6) 8-20 18.5 (2.3) 14-20 14.6 (3.5) 8-20 0.013 
PF 14.3 (4.2) 5-20 17.3 (3.9) 10-20 13.9 (4.1) 5-20 0.052 
MF 11.4 (4.3) 4-20 13.7 (5.5) 7-20 11.1 (4.1) 4-19 0.236 
RM 9.4 (3.6) 4-17 11.8 (3.5) 7-16 9.0 (3.5) 4-17 0.096 
RA 12.6 (4.6) 4-20 15.8 (4.0) 10-20 12.1 (4.6) 4-20 0.075 
FIQ fat 60.0 (29) 0-100 87.3 (12) 71-100 55.7 (28) 0-99 0.008 
GF= general fatigue, PF= physical fatigue, MF=mental fatigue, RM= reduced 
motivation, RA=reduced activity, FIQ fat=FIQ fatigue 
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Gender differences 
Socio-demographic data are given in Table 4 for the women with CWP and 
in Table 5 for men with CWP. There were no statistically significant 
differences between genders in age, employment, being born outside Sweden, 
disability pension and use of analgesics in the patients with CWP. The 
women with CWP reported a longer duration of widespread pain (p=0.023), 
had more tender points (p<0.001) and pain localizations (p=0.004) and a 
higher sick leave (p<0.001) than the men with CWP. There were also a 
higher usage of psychotropic drugs among the women than among the men 
with CWP (p=0.035). A significant difference was also found between the 
genders in education (p=0.006) and whether the patients lived with another 
adult (p=0.030), 84 % of the men with CWP lived with another adult, 
compared with 59 % of the women with CWP (Table 5, Table 6). 
Women with CWP (n=32) scored higher on all five subscales of the MFI-20 
and the FIQ fatigue than men with CWP (n=38) (Tables 14, Table 15), p-
value was 0.013 for MFI general fatigue, 0.004 for MFI physical fatigue, 
0.035 for MFI mental fatigue, 0.026 for MFI reduced motivation, 0.012 for 
MFI reduced activity and 0.008 for FIQ fatigue (the p-values are not shown 
in the tables). 
Logistic regression showed that the differences in fatigue between women 
and men with CWP no longer were significant when adjusted for duration, 
tender points, education, localizations, living with adult, sick leave and use of 
psychotropic drugs. 
Possible differences in fatigue between men and women with FM were not 
analysed due to the low number of men with FM.  
 
5.5   Effects of physiotherapy in women with FM 
and CWP 
No significant baseline differences in socio-demographic data were found 
between the patients (n=166) randomized to either the exercise-education 
group (n=81) or the control group only receiving education (n=85) (paper I, 
Table I). 
No significant change in pharmacological treatment over time was found for 
either of the two groups.  
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5.5.1  20 - week examination 
Intention-to-treat population  
The results of the intention-to-treat analysis including all patients who 
completed the baseline and 20-week examination are presented in Table 16. 
 
Primary outcomes. Significant improvement (p=0.040) was found for change 
in the FIQ total in the exercise-education group (–4.8, SD 13.2) compared 
with change in the education group (–0.7, SD 12.2) after the 20-week study 
period.  
The effect size of the FIQ total for the exercise-education group compared 
with the education group was 0.32. The change in the 6MWT in the exercise-
education group (7.5, SD 53.5) was not statistically significant (p=0.067) 
compared with the change in the education group (–2.0, SD 63.2) after the 
20-week study period.  
Secondary outcomes. Significant improvement (p=0.018) was found for 
change in the FIQ pain in the exercise-education group (–7.8, SD 22.6) 
compared with change in the education group (1.7, SD 19.5) after the 20-
week treatment.  
The effect size of the FIQ pain was 0.45 for the exercise-education group 
compared with the education group. 
Exploratory outcomes. The change in the MFI reduced motivation in the 
exercise-education group (–0.8, SD 3.3) was a significant improvement 
(p=0.046) compared with change in the education group (0.3, SD 3.2). 
Change in the activity related relaxation in the exercise education group (–
0.4, SD 1.2) was also significantly improved (p=0.017) compared with 
change in the education group (0.2, SD 1.4).  
The effect size of the MFI-20 reduced motivation was 0.34, while the effect 
size of the activity related relaxation was 0.45 for the exercise-education 
group compared with the education group.  
Type I error. The secondary and exploratory between-group analyses 
comprised a total of 23 statistical analyses, and the upper limit of expected 
number of false significances was 1.05, which indicates that one of the 
significances found might be false. 
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Per-protocol population 
Forty-seven of 81 patients (58%) randomized to the exercise-education group 
and 56 (66%) of 85 patients randomized to the education group were defined 
as active participants with attendance at at least 60 % of the sessions. The 
results of the per-protocol analyses are presented in Table 16. 
 
Primary outcomes. Significant improvement (p=0.013) was found for the 
change in the FIQ total in the exercise-education group (–6.3, SD 14.4) 
compared with change in the education group (–0.6, SD 12.5) at the 20-week 
post-test.  
The effect size of the FIQ total for the exercise-education group compared 
with the education group was 0.44. Significant improvement (p=0.013) was 
found for the change in the 6MWT in the exercise-education group (14.5, SD 
35.8) compared with the change in the education group (–6.4, SD 58.3) after 
20 weeks. The effect size of the 6MWT for the exercise-education group 
compared with the education group was 0.43.  
Secondary outcomes. Significant improvement (p=0.002) was found for 
change in the FIQ pain (–10.0, SD 18.8) in the exercise-education group 
compared with change in the education group (3.0, SD 18.9).  
The effect size of the FIQ pain for the exercise-education group compared 
with the education group was 0.69.  
The change in the LTPAI total activity (1.0, SD 3.7) was significantly 
increased (p=0.026) in the exercise-education group compared with the 
change in the education group (–0.1, SD 5.06). The greater part of the 
increase was at a moderate level, shown by a significant (p=0.048) change in 
the LTPAI moderate activity (1.3, SD 2.7) in the exercise-education group 
compared with change in the education group (0.2, SD 2.9).  
The effect size of the LTPAI total activity was 0.25, while the effect size of 
the LTPAI moderate activity was 0.39 in the exercise-education group 
compared with the education group. 
Exploratory outcomes. Significant improvement (p=0.005) was found for 
change in the MFI reduced motivation in the exercise-education group (–1.1, 
SD 3.1), compared with the education group (–0.7, SD 3.0), the effect size 
being 0.13.  
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A significant improvement (p=0.002) was also found for change in the 
activity related physical relaxation in the exercise-education group (–0.6, SD 
1.2), compared with the education group (0.4, SD 1.5), as well as for the 
activity related well-being (p=0.021) in the exercise-education group (–0.7, 
SD 1.4) compared with the education group (–0.1, SD 1.4).  
The effect size of activity related relaxation was 0.72, while the effect size of 
activity related well-being was 0.43 in a comparison of the exercise-
education group with the education group.  
Type I error. A total of 23 between-group analyses were made, and the upper 
limit of expected number of false significances was 0.89, which indicates that 
one of the significances found might be false. 
 
5.5.2  11 to 12 - month follow-up  
Intention-to-treat population 
A total of 125 patients (75%) randomized to the study completed the follow-
up at the 11–12-month examination. In the exercise-education group, 
significant improvement was found for change in the 6MWT (14.1, SD 57.6, 
p=0.013), as well as for change in the SF-36 PCS (2.86, SD 8.6, p= 0.006), 
the SF-36 role physical (12.1, SD 40.7, p=0.035) and the SCI-93 (–3.9, SD 
13.2, p=0.011).  
The effect size of the 6MWT was 0.18. The effect size of the SF36 physical 
component was 0.35 and of the SF36 role physical 0.38. The effect size of the 
SCI-93 was 0.17. In the education group, change in the FIQ total (–4.5, SD 
14.3) significantly improved (p=0.024) over time, the effect size being 0.29 
(Table 16).  
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was calculated to be 0.78, which 
indicates that one of the significances found might be false.  
Per-protocol population 
The follow-up outcomes were analysed separately for the PP population. 
Significant improvements over time were found in the exercise-education 
group for: the 6MWT (21.5, SD 48.2; p=0.007), the FIQ pain (–9.1, SD 20.9; 
p=0.019); the SF-36 PCS (3.0, SD 6.7; p=0.002); the SF-36 physical 
functioning (4.2, SD11.1; p=0.024); the SF-36 bodily pain (8.3, SD 32.5; 
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p=0.014); the LTPAI moderate activity (0.8, SD 2.7; p=0.045); and the SCI-
93 (4.5, SD 10.2; p=0.010).  
The effect size was 0.29 for the 6MWT, 0.54 for the FIQ pain, 0.35 for the 
SF36 PCS, 0.43 for SF-36 bodily pain, 0.12 for SF-36 vitality, 0.41 for the 
LTPAI moderate activity, and 0.18 for the SCI-93.  
No significant improvements over time were found in the education group 
(Table 17). 
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was 0.42, which indicates that 0–1 
significances found might be false. 
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limit of expected number of false significances was 0.89, which indicates that 
one of the significances found might be false. 
 
5.5.2  11 to 12 - month follow-up  
Intention-to-treat population 
A total of 125 patients (75%) randomized to the study completed the follow-
up at the 11–12-month examination. In the exercise-education group, 
significant improvement was found for change in the 6MWT (14.1, SD 57.6, 
p=0.013), as well as for change in the SF-36 PCS (2.86, SD 8.6, p= 0.006), 
the SF-36 role physical (12.1, SD 40.7, p=0.035) and the SCI-93 (–3.9, SD 
13.2, p=0.011).  
The effect size of the 6MWT was 0.18. The effect size of the SF36 physical 
component was 0.35 and of the SF36 role physical 0.38. The effect size of the 
SCI-93 was 0.17. In the education group, change in the FIQ total (–4.5, SD 
14.3) significantly improved (p=0.024) over time, the effect size being 0.29 
(Table 16).  
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was calculated to be 0.78, which 
indicates that one of the significances found might be false.  
Per-protocol population 
The follow-up outcomes were analysed separately for the PP population. 
Significant improvements over time were found in the exercise-education 
group for: the 6MWT (21.5, SD 48.2; p=0.007), the FIQ pain (–9.1, SD 20.9; 
p=0.019); the SF-36 PCS (3.0, SD 6.7; p=0.002); the SF-36 physical 
functioning (4.2, SD11.1; p=0.024); the SF-36 bodily pain (8.3, SD 32.5; 
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p=0.014); the LTPAI moderate activity (0.8, SD 2.7; p=0.045); and the SCI-
93 (4.5, SD 10.2; p=0.010).  
The effect size was 0.29 for the 6MWT, 0.54 for the FIQ pain, 0.35 for the 
SF36 PCS, 0.43 for SF-36 bodily pain, 0.12 for SF-36 vitality, 0.41 for the 
LTPAI moderate activity, and 0.18 for the SCI-93.  
No significant improvements over time were found in the education group 
(Table 17). 
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was 0.42, which indicates that 0–1 
significances found might be false. 
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A significant improvement (p=0.002) was also found for change in the 
activity related physical relaxation in the exercise-education group (–0.6, SD 
1.2), compared with the education group (0.4, SD 1.5), as well as for the 
activity related well-being (p=0.021) in the exercise-education group (–0.7, 
SD 1.4) compared with the education group (–0.1, SD 1.4).  
The effect size of activity related relaxation was 0.72, while the effect size of 
activity related well-being was 0.43 in a comparison of the exercise-
education group with the education group.  
Type I error. A total of 23 between-group analyses were made, and the upper 
limit of expected number of false significances was 0.89, which indicates that 
one of the significances found might be false. 
 
5.5.2  11 to 12 - month follow-up  
Intention-to-treat population 
A total of 125 patients (75%) randomized to the study completed the follow-
up at the 11–12-month examination. In the exercise-education group, 
significant improvement was found for change in the 6MWT (14.1, SD 57.6, 
p=0.013), as well as for change in the SF-36 PCS (2.86, SD 8.6, p= 0.006), 
the SF-36 role physical (12.1, SD 40.7, p=0.035) and the SCI-93 (–3.9, SD 
13.2, p=0.011).  
The ffect size of the 6MWT was 0.18. The effect size of the SF36 physical 
component was 0.35 and of the SF36 role physical 0.38. The effect size of the 
SCI-93 was 0.17. In the education group, change in the FIQ total (–4.5, SD 
14.3) significantly improved (p=0.024) over time, the effect size being 0.29 
(Table 16).  
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was calculated to be 0.78, which 
indicates that one of the significances found might be false.  
Per-protocol population 
The follow-up outcom s were analysed separately for the PP population. 
Significant improvements over time were found in the exercise-education 
group for: the 6MWT (21.5, SD 48.2; p=0.007), the FIQ pain (–9.1, SD 20.9; 
p=0.019); the SF-36 PCS (3.0, SD 6.7; p=0.002); the SF-36 physical 
functioning (4.2, SD11.1; p=0.024); the SF-36 bodily pain (8.3, SD 32.5; 
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p=0.014); the LTPAI moderate activity (0.8, SD 2.7; p=0.045); and the SCI-
93 (4.5, SD 10.2; p=0.010).  
The effect size was 0.29 for the 6MWT, 0.54 for the FIQ pain, 0.35 for the 
SF36 PCS, 0.43 for SF-36 bodily pain, 0.12 for SF-36 vitality, 0.41 for the 
LTPAI moderate activity, and 0.18 for the SCI-93.  
No significant improvements over time were found in the education group 
(Table 17). 
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was 0.42, which indicates that 0–1 
significances found might be false. 
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Table 16. Intention-to-treat analysis in study III. Baseline values, change from baseline in outcome variables, within-
group and between-group differences for the exercise education group and the education group. 
  Exercise Education group      Education group         Ex-Edu  
                   vs Edu 
  Baseline ∆20 w  ∆11-12 mo    Baseline  ∆20 w    ∆11-12 mo   20 w 
n=81 n=69  n=63    n=85   n=64     n=62    
 mean (SD)  mean (SD  p mean (SD)     p   mean (SD)  mean (SD)        p  mean (SD) p     p  
Primary outcomes     
FIQ Total 61.6 (16.42)     -4.8 (13.19) 0.006 -3.9 (15.45)  0.077   66.6 (15.30)  -0.7 (12.22) 0.952 -4.5 (14.32)  0.024 0.040 
6MWT 511 (79.7)    7.5 (53.51) 0.047 14.1 (57.59)    0.013     517 (77.2)  -2.0 (63.18) 0.591  3.9 (66.27) 0.800 0.067 
Secondary outcomes   
FIQ Pain 67.7 (16.79)    -7.8 (22.57) 0.007 -6.5 (23.68)    0.119  70.4 (20.05)   1.7 (19.47) 0.674 -2.5 (19.85) 0.252 0.018 
FIQ Fatigue 76.3 (22.49)   -5.0 (25.50) 0.103 -2.7 (24.35)  .486  81.7 (17.64)  -3.8 (19.05) 0.035 -5.5 (21.88) 0.134 0.980 
SF36 PCS 30.8 (8.09)   3.1 (7.70) 0.006  2.86 (8.64)  0.006  29.4 (8.03)   0.6 (8.32) 0.776   1.3 (7.93) 0.234 0.129 
SF36 MCS 40.9 (13.77)  0.4 (10.64) 0.864  0.51 (13.93)  0.561  36.6 (12.29)   2.2 (12.02) 0.040  1.3 (11.26) 0.197 0.146 
SF36 PF 56.6 (19.00) 0.7 (11.98) 0.614  2.19 (14.46)  0.252  50.9 (18. 0)   0.7 (16.79) 0.839  1.3 (16.93) 0.761 0.702 
SF36 RP 22.8 (32.16) 14.8 (44.26) 0.0 8  12.1 (40.68)  0.035  15.2 (26.04)   7.6 (33.34) 0.099  9.3 (43.62) 0.056 0.719 
SF36 BP 28.6 (14.32)  5.1 (16.72) 0.014  5.0 (21.13)  .084  25.7 (16.09)   0.4 (17.07) .650  3.6 (18.22) 0.129 0.236 
SF36 VT 28.4 (21.09)  6.6 (20.67) 0.009  4.2 (23.03)  0.130  24.2 (16.72)   3.9 (21.57) 0.132  .3 (21.02) 0.713 0.377 
HADS Anxiety 8.1 (5.53)  -0.7 (3.01) 0.117 -0.7 (3.30)  0.112  9.1 (4.82)   0.4 (3.39) 0.429  0.4 (3.79) 0.369 0.148 
HADS Depression 6.4 (4.01)  -0.2 (2.98) 0.508 -0.4 (3.26)  0.555  7.8 (3.64)  -0.1 (2.77) 0.748  0.0 (3.15) 0.673 0.993 
LTPAI, total 5.4 (4.06)   1.0 (4.26) 0.036 -0.6 (4.09)  0.309  5.0 (4.23)   0.3 (4.64) 0.861 -0.4 (5.72) 0.811 0.117 
LTPAI, mod 2.0 (2.14)   1.2 (2.91) 0.000 0.2 (2.85)  0.677  2.1 (2.72)   0.3 (2.69) 0.413 -0.5 (3.68) 0.530 0.068 
Exploratory outcomes 
SCI-93  73.3 (23.43) -2.8 (11.97) 0.094 -3.9 (13.23)   0.011  79.4 (26.09)  -0.8 (12.14) 0.650 -2.6 (12.36) 0.339 0.436 
MFI GF 16.9 (2.65)  -0.4 (2.75) 0.394     17.8 (2.30)  -0.8 (3.07) 0.037    0.368 
MFI PF 16.6 (3.06)  -0.6 (2.89) 0.083     17.6 (2.42)  -1.0 (3.80) 0.010     0.544 
MFI RA 15.0 (3.38)  -0.6 (3.09) 0.075     16.0 (3.46)  -1.1 (3.25) 0.008     0.436 
MFI RM 10.2 (3.89)  -0.8 (3.26) 0.040     10.8 (3.75)   0.3 (3.22) 0.451     0.046 
MFI MF 14.4 (4.15)  -0.2 (3.34) 0.585     14.2 (3.86)   0.3 (2.79) 0.408     0.390 
A-Relaxation 4.6 (1.50)  -0.4 (1.22) 0.008     4.6 (1.24)   0.2 (1.44) 0.439    0.017 
A-Wellbeing 2.8 (1.46)  -0.4 (1.41) 0.023     2.9 (1.31)  -0.0 (1.41) 0.486     0.284 
A-Beliefs 2.3 (1.35)   0.1 (1.39) 0.870      2.2 (1.25)   -0.2 (1.02) 0.838     0.983 
A-Symptoms 3.4 (1.23)  -0.1 (1.42) 0.472      3.2 (1.23)  -0.1 (1.59) 0.518    0.993 
A-Habits 3.4 (1.59 )   0.2 (1.58) 0.500      4.0 (1.55)  -0.1 (1.85) 0.768    0.437 
Significant values are sh wn in bold. FIQ=Fibromyalgia Impact Questionnaire. 6MWT= ix minute walk test, SF-36=36-it m short form health survey, PCS=Physical 
Component Summary, MCS=Mental Component Summary, PF=physical functioning, RP=role-physical, BP=bodily pain, VT=vitality, HADS=Hospital Anxiety and 
Depression Scale, LTPAI= Leisure Time Physical Activity Instrument, SCI-93=Stress and Crisis Inventory, MFI=Multidimensional Fatigue Inventory, GF=General 
fatigue, PF=Physical fatigue, RA=Reduced activity, RM=Reduced motivation, MF=Mental fatigue, A=Activity. 
Anna Ericsson 
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Table 17. Per-protocol analysis in study III. Baseline values, change from baseline in outcome variables, within-group 
and between group differences for the active participants in the exercise education group and the education group. 
  Exercise Education group      Education group         Ex-Edu  
                   vs Edu 
  Baseline ∆20 w  ∆11-12 mo   Baseline   ∆20 w    ∆11-12 mo   20 w 
n=47 n=46  n=42   n=56   n=50     n=40    
 mean (SD)  mean (SD  p mean (SD) p  mean (SD)  mean (SD)    p  mean (SD)   p    p  
Primary outcomes    
FIQ Total 61.2 (17.73)    -6.3 (14.41) 0.003 -4.7 (13.45) 0.063 65.9 (15.98)  -0.6 (12.47) 0.881    -4.4 (15.53) 0.121 0.013 
6MWT 507 (75.05)      14.5 (35.79) 0.024 21.5 (48.18) 0.007 511 (71.07)  -6.4 (58.34) 0.287     3.7 (59.53) 0.856 0.013 
Secondary outcomes 
FIQ Pain 68.8 (16.73)    -10.0 (18.83) 0.002 -9.1 (20.89) 0.019 68.3 (19.87)   3.0 (18.92) 0.512    -2.3 (19.69) 0.595 0.002 
FIQ Fatigue 75.1 (23.74)    -7.6 (27.12) 0.063 -4.0 (25.31) 0.473 82.3 (17.76)  -4.7 (19.59) 0.042  -5.6 (21.33) 0.534 0.732 
SF36 PCS 30.4 (8.65)       2.9 (6.28) 0.007 3.0 (6.69) 0.002 29.3 (8.24)  -0.3 (8.73) 0.942   1.4 (8.44) 0.412 0.104 
SF36 MCS 41.9 (14.17)     0.1 (10.21)  0.562  0.0 (11.94) 0.856 36.2 (12.80)    3.8 (12.38) 0.008   1.8 (12.39) 0.162 0.085 
SF3  PF 53.6 (19.64)     1.5 (11.22) 0.346  4.2 (11.08) 0.024 50.6 (16.90)   0.2 (16.42) 0.856   1.3 (17.31) 0.724 0.583 
SF36 RP 26.2 (33.95)     11.4 (40.15) 0.074  8.3 (32.51) 0.134 15.2 (26.83)     9.9 (36.24) 0.079   10.2 (37.06) 0.067 0.697 
SF36 BP 27.9 (15.44)     6.1 (15.07) 0.006  6.7 (15.76) 0.014 25.1 (14.83)   0.7 (16.01) 0.782   4.1 (19.28) 0.207 0.183 
SF36 VT 30.3 (22.15)     6.1 (15.07) 0.021  2.6 (17.47) 0.192 23.0 (16.20)   4.9 (21.09)  0.154   3.3 (22.20) 0.659 0.329 
HADS Anx 8.16 (5.48)      -0.9 (2.74) 0.055 -0.8 (2.76) 0.071 9.15 (5.03)   0.4 (3.38) 0.471  -0.4 (3.87) 0.352 0.099 
HADS Dep 6.21 (4.18)      -0.2 (2.77) 0.327- 0.5 (2.56) 0.418 7.82 (3.41)  -0.3 (2.78) 0.472  -0.0 (3.18) 0.611 0.865 
LTPAI, total 5.6 (4.43)         1.0 (3.68) 0.017 0.0 (3.37) 0.823 5.3 (4.15)  -0.1 (5.06) 0.678  -0.2 (4.99) 0.420 0.026  
LTPAI, mod 1.9 (1.96)         1.3 (2.74) 0.001 0.8 (2.67) 0.045 2.1 (2.90)   0.2 (2.90) 0.654  -0.5 (3.93) 0.802 0.048 
Exploratory outcomes 
SCI- 3  72.3 (24.56)    -3.1 (9.53) 0.053 -4.5 (10.19) 0.010 81.4 (25.24)  -1.1 (9.83) 0.512  -3.2 (12.13) 0.168 0.382 
MFI GF 17.0 (2.76)      -0.5 (2.68) 0.238          18.0 (2.73)   -0.6 (2.93) 0.217 0.819 
MFI PF 16.7 (2.76)      -0.9 (2.71) 0.036          18.0 (2.11)   -0.7 (2.60) 0.074 0.738 
MFI RA 15.3 (3.47)      -1.1 (2.78) 0.010          16.3 (3.02)   -1.0 (3.30) 0.034  0.868 
MFI RM 10.0 (4.05)      -1.1 (3.13) 0.031          10.8 (3.68)   -0.7 (3.02) 0.089 0.005 
MFI MF 14.6 (4.56)       0.1 (3.09) 0.978          14.3 (3.87)     0.5 (2.75) 0.101 0.379 
A-Relaxation 4.8 (1.49)        -0.6 (1.21) 0.001          4.6 (1.31)    0.4 (1.54) 0.198 0.002 
A-Wellbeing 3.0 (1.57)        -0.7 (1.36) 0.001          2.9 (1.35)   -0.1 (1.44) 0.943 0.021 
A-Beliefs 2.5 (1.31)        -0.3 (1.14) 0.102          2.2 (1.36)    0.0 (1.00) 0.984 0.262 
A-Symptoms 3.0 (1.08)         0.3 (1.16) 0.070          3.2 (1.27)   -0.0 (1.62) 0.723 0.294 
A-Habits 3.4 (1.58)        -0.0 (1.66) 0.624          4.0 (1.63)   -0.2 (1.85) 0.603  0.960     
Significant values are shown in bold. FIQ=Fibromyalgia Impact Questionnaire. 6MWT=Six-minute walk test, SF-36=36-item short form health survey, PCS=Physical 
Component Summary, MCS=Mental Component Summary, PF=physical functioning, RP=role-physical, BP=bodily pain, VT=vitality, HADS=Hospital Anxiety and 
Depression Scale, LTPAI= Leisure Time Physical Activity Instrument, SCI-93=Stress and Crisis Inventory, MFI=Multidimensional Fatigue Inventory, GF=General 
fatigue, PF=Physical fatigue, RA=Reduced activity, RM=Reduced motivation, MF=Mental fatigue, A=Activity.
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A significant improvement (p=0.002) was also found for change in the 
activity related physical relaxation in the exercise-education group (–0.6, SD 
1.2), compared with the education group (0.4, SD 1.5), as well as for the 
activity related well-being (p=0.021) in the exercise-education group (–0.7, 
SD 1.4) compared with the education group (–0.1, SD 1.4).  
The effect size of activity related relaxation was 0.72, while the effect size of 
activity related well-being was 0.43 in a comparison of the exercise-
education group with the education group.  
Type I error. A total of 23 between-group analyses were made, and the upper 
limit of expected number of false significances was 0.89, which indicates that 
one of the significances found might be false. 
 
5.5.2  11 to 12 - month follow-up  
Intention-to-treat population 
A total of 125 patients (75%) randomized to the study completed the follow-
up at the 11–12-month examination. In the exercise-education group, 
significant improvement was found for change in the 6MWT (14.1, SD 57.6, 
p=0.013), as well as for change in the SF-36 PCS (2.86, SD 8.6, p= 0.006), 
the SF-36 role physical (12.1, SD 40.7, p=0.035) and the SCI-93 (–3.9, SD 
13.2, p=0.011).  
The effect size of the 6MWT was 0.18. The effect size of the SF36 physical 
component was 0.35 and of the SF36 role physical 0.38. The effect size of the 
SCI-93 was 0.17. In the education group, change in the FIQ total (–4.5, SD 
14.3) significantly improved (p=0.024) over time, the effect size being 0.29 
(Table 16).  
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was calculated to be 0.78, which 
indicates that one of the significances found might be false.  
Per-protocol population 
The follow-up outcomes were analysed separately for the PP population. 
Significant improvements over time were found in the exercise-education 
group for: the 6MWT (21.5, SD 48.2; p=0.007), the FIQ pain (–9.1, SD 20.9; 
p=0.019); the SF-36 PCS (3.0, SD 6.7; p=0.002); the SF-36 physical 
functioning (4.2, SD11.1; p=0.024); the SF-36 bodily pain (8.3, SD 32.5; 
Anna Ericsson 
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p=0.014); the LTPAI moderate activity (0.8, SD 2.7; p=0.045); and the SCI-
93 (4.5, SD 10.2; p=0.010).  
The effect size was 0.29 for the 6MWT, 0.54 for the FIQ pain, 0.35 for the 
SF36 PCS, 0.43 for SF-36 bodily pain, 0.12 for SF-36 vitality, 0.41 for the 
LTPAI moderate activity, and 0.18 for the SCI-93.  
No significant improvements over time were found in the education group 
(Table 17). 
Type I error. A total of 15 analyses were made, and the upper limit of 
expected number of false significances was 0.42, which indicates that 0–1 
significances found might be false. 
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Table 16. Intention-to-treat analysis in study III. Baseline values, change from baseline in outcome variables, within-
group and between-group differences for the exercise education group and the education group. 
  Exercise Education group      Education group         Ex-Edu  
                   vs Edu 
  Baseline ∆20 w  ∆11-12 mo    Baseline  ∆20 w    ∆11-12 mo   20 w 
n=81 n=69  n=63    n=85   n=64     n=62    
 mean (SD)  mean (SD  p mean (SD)     p   mean (SD)  mean (SD)        p  mean (SD)  p     p  
Primary outcomes     
FIQ Total 61.6 (16.42)     -4.8 (13.19) 0.006 -3.9 (15.45)  0.077   66.6 (15.30)  -0.7 (12.22) 0.952 -4.5 (14.32)  0.024 0.040 
6MWT 511 (79.7)    7.5 (53.51) 0.047 14.1 (57.59)    0.013     517 (77.2)  -2.0 (63.18) 0.591  3.9 (66.27) 0.800 0.067 
Secondary outcomes   
FIQ Pain 67.7 (16.79)    -7.8 (22.57) 0.007 -6.5 (23.68)    0.119  70.4 (20.05)   1.7 (19.47) 0.674 -2.5 (19.85) 0.252 0.018 
FIQ Fatigue 76.3 (22.49)   -5.0 (25.50) 0.103 -2.7 (24.35)  0.486  81.7 (17.64)  -3.8 (19.05) 0.035 -5.5 (21.88) 0.134 0.980 
SF36 PCS 30.8 (8.09)   3.1 (7.70) 0.006  2.86 (8.64)  0.006  29.4 (8.03)   0.6 (8.32) 0.776   1.3 (7.93) 0.234 0.129 
SF36 MCS 40.9 (13.77)  0.4 (10.64) 0.864  0.51 (13.93)  0.561  36.6 (12.29)   2.2 (12.02) 0.040  1.3 (11.26) 0.197 0.146 
SF36 PF 56.6 (19.00) 0.7 (11.98) 0.614  2.19 (14.46)  0.252  50.9 (18. 0)   0.7 (16.79) 0.839  1.3 (16.93) 0.761 0.702 
SF36 RP 22.8 (32.16) 14.8 (44.26) 0.008  12.1 (40.68)  0.035  15.2 (26.04)   7.6 (33.34) 0.099  9.3 (43.62) 0.056 0.719 
SF36 BP 28.6 (14.32)  5.1 (16.72) 0.014  5.0 (21.13)  0.084  25.7 (16.09)   0.4 (17.07) 0.650  3.6 (18.22) 0.129 0.236 
SF36 VT 28.4 (21.09)  6.6 (20.67) 0.009  4.2 (23.03)  0.130  24.2 (16.72)   3.9 (21.57) 0.132  .3 (21.02) 0.713 0.377 
HADS Anxiety 8.1 (5.53)  -0.7 (3.01) 0.117 -0.7 (3.30)  0.112  9.1 (4.82)   0.4 (3.39) 0.429  0.4 (3.79) 0.369 0.148 
HADS Depression 6.4 (4.01)  -0.2 (2.98) 0.508 -0.4 (3.26)  0.555  7.8 (3.64)  -0.1 (2.77) 0.748  0.0 (3.15) 0.673 0.993 
LTPAI, total 5.4 (4.06)   1.0 (4.26) 0.036 -0.6 (4.09)  0.309  5.0 (4.23)   0.3 (4.64) 0.861 -0.4 (5.72) 0.811 0.117 
LTPAI, mod 2.0 (2.14)   1.2 (2.91) 0.000 0.2 (2.85)  0.677  2.1 (2.72)   0.3 (2.69) 0.413 -0.5 (3.68) 0.530 0.068 
Exploratory outcomes 
SCI-93  73.3 (23.43) -2.8 (11.97) 0.094 -3.9 (13.23)   0.011  79.4 (26.09)  -0.8 (12.14) 0.650 -2.6 (12.36) 0.339 0.436 
MFI GF 16.9 (2.65)  -0.4 (2.75) 0.394     17.8 (2.30)  -0.8 (3.07) 0.037    0.368 
MFI PF 16.6 (3.06)  -0.6 (2.89) 0.083     17.6 (2.42)  -1.0 (3.80) 0.010     0.544 
MFI RA 15.0 (3.38)  -0.6 (3.09) 0.075     16.0 (3.46)  -1.1 (3.25) 0.008     0.436 
MFI RM 10.2 (3.89)  -0.8 (3.26) 0.040     10.8 (3.75)   0.3 (3.22) 0.451     0.046 
MFI MF 14.4 (4.15)  -0.2 (3.34) 0.585     14.2 (3.86)   0.3 (2.79) 0.408     0.390 
A-Relaxation 4.6 (1.50)  -0.4 (1.22) 0.008     4.6 (1.24)   0.2 (1.44) 0.439    0.017 
A-Wellbeing 2.8 (1.46)  -0.4 (1.41) 0.023     2.9 (1.31)  -0.0 (1.41) 0.486     0.284 
A-Beliefs 2.3 (1.35)   0.1 (1.39) 0.870      2.2 (1.25)   -0.2 (1.02) 0.838     0.983 
A-Symptoms 3.4 (1.23)  -0.1 (1.42) 0.472      3.2 (1.23)  -0.1 (1.59) 0.518    0.993 
A-Habits 3.4 (1.59 )   0.2 (1.58) 0.500      4.0 (1.55)  -0.1 (1.85) 0.768    0.437 
Significant values are shown in bold. FIQ=Fibromyalgia Impact Questionnaire. 6MWT= ix minute walk test, SF-36=36-item short form health survey, PCS=Physical 
Component Summary, MCS=Mental Component Summary, PF=physical functioning, RP=role-physical, BP=bodily pain, VT=vitality, HADS=Hospital Anxiety and 
Depression Scale, LTPAI= Leisure Time Physical Activity Instrument, SCI-93=Stress and Crisis Inventory, MFI=Multidimensional Fatigue Inventory, GF=General 
fatigue, PF=Physical fatigue, RA=Reduced activity, RM=Reduced motivation, MF=Mental fatigue, A=Activity. 
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Table 17. Per-protocol analysis in study III. Baseline values, change from baseline in outcom  variables, within-group 
and between group differences for the active participants in the exercise education group and the education group. 
  Exercise Education group      Education group         Ex-Edu  
                   vs Edu 
  Baseline ∆20 w  ∆11-12 mo   Baseline   ∆20 w    ∆11-12 mo   20 w 
n=47 n=46  n=42   n=56   n=50     n=40    
 mean (SD)  mean (SD  p mean (SD) p  mean (SD)  mean (SD)    p  mean (SD)   p    p  
Primary outcomes    
FIQ Total 61.2 (17.73)    -6.3 (14.41) 0.003 -4.7 (13 45) 0.063 65.9 (15.98)  -0.6 (12.47) 0.881    -4.4 (15.53) 0.121 0.013 
6MWT 507 (75.05)      14.5 (35.79) 0.024 21.5 (48.18) 0.007 511 (71.07)  -6.4 (58.34) 0.287     3.7 (59.53) 0.856 0.013 
Secondary outcomes 
FIQ Pain 68.8 (16.73)    -10.0 (18.83) 0.002 -9.1 (20.89) 0.019 68.3 (19.87)   3.0 (18.92) 0.512    -2.3 (19.69) 0.595 0.002 
FIQ Fatigue 75.1 (23.74)    -7.6 (27.1 ) 0.063 -4.0 (25.31) 0.473 82.3 (17.76)  -4.7 (19.59) 0.042  -5.6 (21.33) 0.534 0.732 
SF36 PCS 30.4 (8.65)       2.9 (6.28) 0.007 3.0 (6.69) 0.002 29.3 (8.24)  -0.3 (8.73) 0.942   1.4 (8.44) 0.412 0.104 
SF36 MCS 41.9 (14.17)     0.1 (10.21)  0.562  0.0 (11.94) 0.856 36.2 (12.80)    3.8 (12.38) 0.008   1.8 (12.39) 0.162 0.085 
SF3  PF 53.6 (19.64)     1.5 (11.22) 0.3 6  4.2 (11.08) 0.024 50.6 (16.90)   0.2 (16.42) 0.856   1.3 (17.31) 0.724 0.583 
SF36 RP 26.2 (33.95)     11.4 (40.15) 0.074  8.3 (32.51) .134 15.2 (26.83)     9.9 (36.24) 0.079   10.2 (37.06) 0.067 0.697 
SF36 BP 27.9 (15.44)     6.1 (15.07) 0.0 6  6.7 (15.76) .014 25.1 (14.83)   0.7 (16. 1) .782   4.1 (19.28) 0.207 0.183 
SF36 VT 30.3 (22.15)     6.1 (15.07) 0.021  2.6 (17.47) 0.192 23.0 (16.20)   4.9 (21.09)  0.154   3.3 (22.20) 0.659 0.329 
HADS Anx 8.16 (5.48)      -0.9 (2.74) 0.055 -0.8 (2.76) 0.071 9.15 (5.03)   0.4 (3.38) 0.471  -0.4 (3.87) 0.352 0.099 
HADS Dep 6.21 (4.18)      -0.2 (2.77) 0.327- 0.5 (2.56) 0.418 7.82 (3.41)  -0.3 (2.78) 0.472  -0.0 (3.18) 0.611 0.865 
LTPAI, total 5.6 (4.43)         1.0 (3.68) 0.017 0.0 (3.37) 0.823 5.3 (4.15)  -0.1 (5.06) 0.678  -0.2 (4.99) 0.420 0.026  
LTPAI, mod 1.9 (1.96)         1.3 (2.74) 0.001 0.8 (2.67) 0.045 2.1 (2.90)   0.2 (2.90) 0.654  -0.5 (3.93) 0.802 0.048 
Exploratory outcomes 
SCI- 3  72.3 (24.56)    -3.1 (9.53) 0.053 -4.5 (10.19) 0.010 81.4 (25.24)  -1.1 (9.83) 0.512  -3.2 (12.13) 0.168 0.382 
MFI GF 17.0 (2.76)      -0.5 (2.68) 0.238          18.0 (2.73)  -0.6 (2.93) 0.217 0.819 
MFI PF 16.7 (2.76)      -0.9 (2.71) 0.036          18.0 (2.11)   -0.7 (2.60) 0.074 0.738 
MFI RA 15.3 (3.47)      -1.1 (2.78) 0.010          16.3 (3.02)   -1.0 (3.30) 0.034  0.868 
MFI RM 10.0 (4.05)      -1.1 (3.13) 0.031          10.8 (3.68)   -0.7 (3.02) 0.089 0.005 
MFI MF 14.6 (4.56)       0.1 (3.09) 0.978          14.3 (3.87)     0.5 (2.75) 0.101 0.379 
A-Relaxation 4.8 (1.49)        -0.6 (1.21) 0.001          4.6 (1.31)    0.4 (1.54) 0.198 0.002 
A-Wellbeing 3.0 (1.57)        -0.7 (1.36) 0.001          2.9 (1.35)   -0.1 (1.44) 0.943 0.021 
A-Beliefs 2.5 (1.31)        -0.3 (1.14) 0.102          2.2 (1.36)    0.0 (1.00) 0.984 0.262 
A-Symptoms 3.0 (1.08)         0.3 (1.16) 0.070          3.2 (1.27)   -0.0 (1.62) 0.723 0.294 
A-Habits 3.4 (1.58)        -0.0 (1.66) 0.624          4.0 (1.63)   -0.2 (1.85) 0.603  0.960     
Significant values are shown in bold. FIQ=Fibromyalgia Impact Questionnaire. 6MWT=Six-minute walk test, SF-36=36-item short form health survey, PCS=Physical 
Component Summary, MCS=Mental Component Summary, PF=physical functioning, RP=role-physical, BP=bodily pain, VT=vitality, HADS=Hospital Anxiety and 
Depression Scale, LTPAI= Leisure Time Physical Activity Instrument, SCI-93=Stress and Crisis Inventory, MFI=Multidimensional Fatigue Inventory, GF=General 
fatigue, PF=Physical fatigue, RA=Reduced activity, RM=Reduced motivation, MF=Mental fatigue, A=Activity.
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5.5.3 Subgroup analysis 
The results of the sub-group analysis are illustrated in Figure 7.  
FIQ Total 
No significant heterogeneity was found for the subgroups created by level of 
pain, distress, stress and activity limitations, implying that these aspects did 
not have any significant influence on change in the FIQ total score. However, 
a non-significant tendency towards heterogeneity (p=0.073) was found for 
the subgroup created by the SCI-93 (<78/≥78), implying that the 
improvement in the FIQ total tended to be influenced by stress, in favor of 
those with lower stress scores.  
Analysis within the subgroup characterized by the lower degree of stress 
(<78 on the SCI-93) revealed a significant (p=0.013) improvement in the FIQ 
total in the exercise-education group (–6.0, SD 15.2) compared with change 
in the control group only receiving education (2.9, SD 11.4), the effect size 
for the exercise-education group compared with the control group being 0.64.  
A significant improvement (p=0.042) was also found for change in the FIQ 
total (–4.7, SD 15.1) in the exercise-education group characterized by lower 
ratings on the FIQ pain (< 70), compared with change in the education group 
(2.8, SD 12.2), the effect size for the exercise-education group compared with 
the education group being 0.54.  
A significant improvement (p=0.025) was also found for change in the FIQ 
total (–5.0, SD 13.8) in the patients in the exercise-education group reporting 
a lower level of distress (< 8 on the HADS-D), compared with change in the 
education group (2.2, SD 13.3), the effect size for the exercise-education 
group compared with the education group being 0.53.  
No significant change in the FIQ total was found in the analyses comparing 
patients with more severe scores, randomized either to exercise-education or 
education only, in scores on the SCI-93 (p=0.723), the FIQ pain (p=0.530) or 
HADS-D (p=0.911). 
6MWT 
No significant heterogeneity was found for the subgroups created by the level 
of pain, distress, stress and activity limitations implying their influence on the 
change score of the 6MWT. 
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Figure 7. Subgroup influences on change in the primary outcomes in study III. (a) 
Fibromyalgia Impact Questionnaire (FIQ) total. (b) Six-minute walk test (6MWT). The 
subgroups were created by dichotomized values of the Stress and Crisis Inventory (SCI), 
the FIQ pain, the Hospital Anxiety and Depression Scale (HADS), and the 36-item Short-
Form Health Survey (SF36) physical functioning. Mean differences for the change score 
and 95% confidence intervals (CI) are presented in the graphs, followed by p-value, 
separately for each subgroup. The p-value for heterogeneity (interaction between the 
randomized group and the change score of the primary outcome) is given in the right-
hand column. ITT: intention-to-treat.*Fisher’s Non-Parametric Permutation test.
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5.6 Effects of physiotherapy in men with CWP 
The socio-demographic data of the pool exercise group, the resistance 
training group and the reference group in the male population are given in 
paper IV, Table 1. Baseline values, change from baseline in outcome 
variables, within-group and between-group differences for the pool exercise 
group and the resistance training group are given in paper IV, Table 3. 
No significant baseline differences in socio-demographic data or outcome 
variables were found between the pool exercise group (n=14) and the 
resistance training group (n=14). 
5.6.1  12 - week examination in the randomized trial 
The mean attendance at the sessions for the patients completing the 12-week 
examination was 80 % (SD 17) in the pool exercise group (n=12) and 89 % 
(SD 6) in the resistance training group (n=10). 
In the resistance training group, the initial load at week 1 was 40-50 % of 1 
RM, with three sets of 15-20 repetitions. The mean increase in load from 
week 1 to week 12 was found to be between 37 % and 53 % for the different 
exercises. 
Between-group comparisons  
Primary outcomes. No statistically significant differences were found for 
change in the MFI-20 at the 12-week examination between the pool exercise 
group and the resistance training group. 
Secondary outcomes. A significantly higher improvement was found at the 
12-week examination for change in isometric force of the right arm shoulder 
abduction (p=0.010) and knee flexion in both legs (right: p=0.005, left: 
p=0.002) in the resistance training group, as compared to the change over 
time in the pool exercise group. 
Exploratory outcomes. No statistically significant differences were found for 
change in FIQ pain, pain localizations or SF-36 at the 12-week examination 
between the pool exercise group and the resistance training group. 
Type 1 error. The secondary and exploratory outcomes in the between-group 
analyses at the 12-week examination comprised a total of 14 statistical 
analyses, and the upper limit of expected number of false significances was 
0.58, which indicates that one of the significances found might be false. 
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Changes over time within the two exercise groups  
Pool exercise group. MFI reduced motivation (p=0.008), HADS-A (p=0.032) 
and the SF-36 PCS (p=0.010) were significantly improved over baseline at 
the 12-week examination in the pool exercise group. 
Resistance training group. MFI general fatigue (p=0.035) as well as 
isometric force of the right arm shoulder abduction (p=0.008), knee flexion 
(right leg: p=0.017, left leg: p=0.005) and right hand grip (p=0.009) and 
number of pain localizations (p=0.014) were significantly improved over 
baseline at the 12-week examination in the resistance training group. 
Type 1 error. The secondary and exploratory within-group analyses at the 12-
week examination for the two exercise groups comprised a total of 28 
statistical analyses, and the upper limit of expected number of false 
significances was 1.11, which indicates that one of the significances found 
might be false. 
5.6.2  9 - month follow-up in the randomized trial 
Between-group comparisons 
Primary outcomes. No statistically significant differences were found for 
change in MFI-20 at the nine-month follow-up between the pool exercise 
group and the resistance training group. 
Secondary outcomes. A significantly greater improvement was found at the 
nine-month follow-up for change in isometric force of the right arm shoulder 
abduction (p=0.043) in the resistance training group, as compared to the 
change over time in the pool exercise group. 
Exploratory outcomes. No statistically significant differences were found for 
change in pain intensity, pain localization or SF-36 at the nine-month follow-
up between the pool exercise group and the resistance training group. 
Type 1 error. The secondary and exploratory between-group analyses at the 
nine-month follow-up comprised a total of 14 statistical analyses, and the 
upper limit of expected number of false significances was 0.68, which 
indicates that one of the significances found might be false. 
Changes over time within the two exercise groups 
Pool exercise group. Significant improvement was found in the pool exercise 
group at the nine-month follow-up for change in HADS-A (p=0.019), SF-36 
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Changes over time within the two exercise groups  
Pool exercise group. MFI reduced motivation (p=0.008), HADS-A (p=0.032) 
and the SF-36 PCS (p=0.010) were significantly improved over baseline at 
the 12-week examination in the pool exercise group. 
Resistance training group. MFI general fatigue (p=0.035) as well as 
isometric force of the right arm shoulder abduction (p=0.008), knee flexion 
(right leg: p=0.017, left leg: p=0.005) and right hand grip (p=0.009) and 
number of pain localizations (p=0.014) were significantly improved over 
baseline at the 12-week examination in the resistance training group. 
Type 1 error. The secondary and exploratory within-group analyses at the 12-
week examination for the two exercise groups comprised a total of 28 
statistical analyses, and the upper limit of expected number of false 
significances was 1.11, which indicates that one of the significances found 
might be false. 
5.6.2  9 - month follow-up in the randomized trial 
Between-group comparisons 
Primary outcomes. No statistically significant differences were found for 
change in MFI-20 at the nine-month follow-up between the pool exercise 
group and the resistance training group. 
Secondary outcomes. A significantly greater improvement was found at the 
nine-month follow-up for change in isometric force of the right arm shoulder 
abduction (p=0.043) in the resistance training group, as compared to the 
change over time in the pool exercise group. 
Exploratory outcomes. No statistically significant differences were found for 
change in pain intensity, pain localization or SF-36 at the nine-month follow-
up between the pool exercise group and the resistance training group. 
Type 1 error. The secondary and exploratory between-group analyses at the 
nine-month follow-up comprised a total of 14 statistical analyses, and the 
upper limit of expected number of false significances was 0.68, which 
indicates that one of the significances found might be false. 
Changes over time within the two exercise groups 
Pool exercise group. Significant improvement was found in the pool exercise 
group at the nine-month follow-up for change in HADS-A (p=0.019), SF-36 
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PCS (p=0.017) and number of pain localizations (p=0.012), as compared to 
baseline. 
Resistance training group. Significant improvement was found in the 
resistance training group at the nine-month follow-up for change in MFI 
general fatigue (p=0.034) and MFI physical fatigue (p=0.034), as compared 
to baseline. Significant improvements were also found in the resistance 
training group for right arm shoulder abduction (p=0.021) and the number of 
pain localizations (p=0.027) at the nine-month follow-up, as compared to 
baseline. 
Type 1 error. The secondary and exploratory within-group analyses at the 
nine-month follow-up comprised a total of 28 statistical analyses, and the 
upper limit of expected number of false significances was 1.21, which 
indicates that one of the significances found might be false. 
5.6.3 Reference group 
No statistically significant differences were found at baseline in socio-
demographic data or MFI-20 subscales when the reference group (n=10) was 
compared to the pool exercise group (n=14) and the resistance training group 
(n=14). Three patients in the reference group were lost to follow-up at the 12-
week examination (Figure 2). No statistically significant change in outcome 
variables was found for the reference group at the 12-week examination, as 
compared to baseline. 
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6 DISCUSSION 
6.1 The MFI-20 
6.1.1 Validity 
The convergent construct validity of the Swedish version of the MFI-20 was 
investigated by comparing the five subscales of the MFI-20 with the one-
dimensional FIQ fatigue. All five subscales of the MFI-20 showed a 
statistically significant association with the FIQ fatigue for both female and 
male patients with FM or CWP. Correlation values with FIQ fatigue were 
lowest for MFI reduced motivation and highest for MFI general fatigue in 
both populations, with values ranging from 0.32 to 0.62 in the female 
population and 0.55 to 0.78 in the male population.   
The relatively low correlation values indicate that the subscales of the MFI-
20 assess different aspects of fatigue than does the FIQ fatigue. MFI general 
fatigue showed the highest correlation value with FIQ fatigue in both the 
female and the male populations, which was expected since both ratings 
could be considered to comprehend a more global aspect of fatigue. These 
results are consistent with findings in female patients with primary Sjögren´s 
syndrome, where the correlation values with the VAS for global fatigue 
ranged from 0.31 for MFI reduced motivation to 0.70 for MFI general fatigue 
(d'Elia et al., 2008). Similar results have also been found in studies of patients 
with rheumatoid arthritis (Rupp, et al., 2004) and patients with cancer 
(Smets, et al., 1995), in which MFI general fatigue showed the highest 
association with a VAS for global fatigue.  
The Swedish version of the MFI-20 appears to possess acceptable convergent 
construct validity, when compared to a one-dimensional scale. Unfortunately, 
there was no established multidimensional rating of fatigue to use in 
comparisons with the MFI-20, which would have given more valuable 
information about the accuracy of the different subscales. Another approach 
to investigating the convergent validity of the MFI-20 has been applied in a 
study in a general population, in which the subscales of the MFI-20 were 
correlated with variables previously shown to be associated with fatigue, such 
as depression, anxiety and health related quality of life (Lin et al., 2009). 
There are further aspects that need to be considered when establishing the 
validity of an instrument. When the MFI-20 was originally developed, the 
construct validity of the subscales was investigated by comparing the results 
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of different populations expected to differ in the subscales of fatigue, such as 
patients with cancer, patients with ME, army recruits, psychology students 
and medical students. Factor analyses of the MFI-20 were also conducted in 
all populations, which supported the five subscales of the MFI-20 (Smets, et 
al., 1995).  
6.1.2 Reliability 
The test-retest reliability of the Swedish version of the MFI-20 was 
investigated in female and male patients with FM and CWP. The ICC values 
for the five subscales of the MFI-20 ranged from 0.75 to 0.92 in the female 
population and from 0.83 to 0.94 in the male population. According to the 
interpretation of the ICC values (Fleiss, 1986), the subscales possessed 
excellent test-retest reliability for the female and the male patients with FM 
and CWP. The 95 % confidence intervals of the ICC values were above the 
limit of 0.4, indicating satisfactory reliability for all five subscales of the 
MFI-20 in both populations.. 
In a study of women with primary Sjögren´s syndrome that investigated the 
test-retest reliability of the MFI-20 with a mean of two weeks between the 
test occasions, the ICC values ranged from 0.65 to 0.80 for the five subscales 
(d'Elia, et al., 2008). In a similar study in patients with ankylosing 
spondylitis, with six weeks between the two tests, the ICC values ranged 
from 0.57 to 0.75 (van Tubergen, et al., 2002). In the present study of FM 
and CWP, an interval of one to two days between test and retest was 
accepted.  It appears that a longer interval results in lower ICC values, 
probably due to the fluctuating nature of fatigue.  
The means of differences between the two test occasions were also low, 
around zero. However, there were patients fluctuating up to eight points 
between test and retest. Patients with FM have described fluctuations in 
fatigue on a day-to-day basis (Sallinen, et al., 2011), which complicates test-
retest reliability analyses 
The risk of recall bias was considered to be small in the present test-retest 
reliability study. The patients completed a great number of questionnaires, 
including the MFI-20, at the first test occasion and were not informed about 
which instrument they would complete the day after. 
A systematic difference was found in the female population for the subscale 
of physical fatigue, indicating that the female patients were more physically 
fatigued at the second occasion. This increase in physical fatigue might be 
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due to the physical tests the patients performed directly after the first test 
occasion. 
Additional analyses not included in papers I to IV were made in the present 
thesis to investigate the internal consistency of the Swedish version of the 
MFI-20 in patients with FM and CWP.  The Cronbach´s alpha ranged from 
0.65 to 0.82 in the female population and from 0.65 to 0.89 in the male 
population, for the five subscales of the MFI-20. MFI reduced motivation 
showed the lowest Cronbach´s alpha value in both populations, being close to 
0.7, which is considered an acceptable limit.  
6.1.3  Usefulness 
The FIQ is a well-accepted and frequently used instrument for assessing 
disabilities and symptoms in FM. The subscale of fatigue included in the FIQ 
assesses only one global dimension of fatigue, for which reason it would be 
preferable to add the MFI-20 as a complement to obtain a deeper and more 
variegated picture of the patients´ fatigue. However, since the MFI-20 is a 
more comprehensive and time consuming instrument, it is of interest to 
investigate the context in which the examination would benefit from 
inclusion of the MFI-20 and where the more global assessment FIQ fatigue 
would be sufficient.  
There is a lack of similar studies comparing two instruments with regard to 
the field of application. We chose to compare the MFI-20 and the FIQ fatigue 
by correlating the two instruments with socio-demographic data and health 
related variables previously shown to be associated with fatigue, as well as 
investigating explanatory variables of severe fatigue. 
The present study found that the MFI-20, and especially its subscales of 
physical fatigue and reduced activity, appears to contribute valuable aspects 
of fatigue associated with employment, physical activity and walking 
capacity, which the FIQ fatigue does not. However, the FIQ fatigue and the 
MFI-20 possessed an equivalent ability to assess associations with pain, sleep 
and symptoms of depression and anxiety. Thus, the FIQ fatigue may be 
sufficient in studies of fatigue in relation to these aspects.  
In the analyses of explanatory variables of severe fatigue, the MFI reduced 
activity differed the most from the FIQ fatigue. Higher age, less work hours 
per week, more symptoms of depression and less physical activity explained 
severely reduced activity, while severe FIQ fatigue was explained by high 
pain intensity, disturbed sleep quality and more symptoms of depression. 
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These results emphasize the recommendation to use the MFI-20 in relation to 
aspects of employment and physical function. 
6.2 Dimensions of fatigue in FM and CWP 
Fatigue is a symptom of substantial importance for patients with FM 
(Guymer & Clauw, 2002; Yunus, 2007), affecting their daily life negatively 
(Liedberg & Henriksson, 2002; Wuytack & Miller, 2011).  Fatigue has been 
reported as the third most distressing symptom in women with FM who are 
over 50 years of age, following fear of symptoms worsening and difficulty 
staying asleep (Shillam, Dupree Jones, & Miller, 2011).  
In the present thesis, the fatigue in patients with FM and CWP was 
investigated and described in multiple dimensions assessed with the MFI-20. 
The mean scores of the MFI-20 ranged from 10.5 to 17.4 in the women with 
FM and CWP and from 9.4 to 15.2 in the men with FM and CWP in the 
present thesis. Both the female and the male population scored lowest on 
MFI reduced motivation and highest on MFI general fatigue. The fatigue 
scores in the female population are similar to findings in women with 
primary Sjögren´s syndrome, where the mean scores of the MFI-20 subscales 
ranged from 12.0 for MFI reduced motivation to 17.9 for MFI general 
fatigue. 
In other rheumatic diseases, the mean MFI-20 scores have been shown to 
range between 8.2 for MFI mental fatigue and 13.4 for MFI general fatigue in 
patients with rheumatoid arthritis (Rupp, et al., 2004) and between 10.1 for 
MFI mental fatigue and 15.5 for MFI general fatigue in patients with 
ankylosing spondylitis (van Tubergen, et al., 2002). However, those studies 
included both men and women (Rupp, et al., 2004; van Tubergen, et al., 
2002). 
In the present thesis, women with FM scored significantly higher on all five 
subscales of the MFI-20, as well as the FIQ fatigue, than the reference group 
of healthy women did. The mean scores of the healthy reference group 
ranged from 7.8 for MFI reduced motivation to 10.7 for MFI general fatigue, 
which is consistent with the results in another healthy female population 
(d'Elia, et al., 2008). The ability of MFI-20 to demonstrate significantly 
different scores between the patients with FM and the healthy reference 
group could be regarded as a measure of known group validity of the 
instrument, since women with FM are expected to be more fatigued than 
healthy women. 
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Female patients with FM and CWP showed high ratings of perceived fatigue, 
especially on the dimensions of MFI general fatigue and MFI physical 
fatigue. There is little knowledge about the etiology of their fatigue, but it has 
been suggested that it can be partly explained by central sensitization (Casale 
& Rainoldi, 2011; Yunus, 2007). Patients with FM have also been found to 
have a hypoactive sympatho-adrenal system, a hypo-reactive hypothalamic-
pituitary axis during static exercise (Kadetoff & Kosek, 2010) and reduced 
muscle blood flow during static exercise and after dynamic exercise (Elvin, 
Siosteen, Nilsson, & Kosek, 2006). This muscle ischemia has been suggested 
to contribute to the pain experienced by patients with FM during and after 
exercise (Elvin, et al., 2006). There is a possibility that the muscle ischemia 
also contributes to physical fatigue in FM. Physical fatigue was explained by 
pain intensity alone in women with FM in the present thesis.  
6.2.1 Gender differences 
Additional analyses not included in papers I to IV were made in comparisons 
of multidimensional fatigue between men and women with CWP. The 
women with CWP rated their fatigue significantly higher than the men with 
CWP for all MFI-20 subscales and the FIQ fatigue. However, when the 
results were adjusted for socio-demographic data that differed between the 
two groups of genders, the difference in fatigue were no longer statistically 
significant for the MFI-20 or the FIQ fatigue. Previous findings have shown 
that women rate their fatigue higher than men in patients with FM (Nicassio, 
et al., 2002; Yunus, 2001) as well as in the general population (Watt, et al., 
2000).  
Gender has been found to play a role in how patients with chronic pain 
manage their symptoms.  Women with chronic pain rate their physical 
function lower (Rutledge, et al., 2007) and have greater difficulty retaining 
positive effects of pain management programmes than men (Keogh, et al., 
2005). Pain also results in disability pension for women to a greater extent 
than men (Gjesdal, Bratberg, & Maeland, 2011).  
The cause of gender differences in FM and CWP in symptoms and effects of 
treatments is probably complex and multi-factorial, with both biological and 
psychological explanations, such as socialization, cognitive factors and 
affective factors (Myers, Riley, & Robinson, 2003). The role of gender in 
coping strategies has been studied in patients with pain, and women reported 
significantly greater use of palliative behaviors, positive self-statements, and 
problem solving and appeared to seek social support more often than men did 
(Unruh, Ritchie, & Merskey, 1999). Findings in healthy adults also indicate 
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that men and women hold different gender specific expectations on pain 
coping strategies (Keogh & Denford, 2009).  
6.3 Effects of physiotherapy 
Effects of different types of treatment are continuously studied in FM and 
CWP. A previous study investigated treatment effects in patients with FM 
and showed that improvements in pain, fatigue, depression, anxiety, physical 
function and impact of daily living were associated with a subjective 
impression of improvement (Hudson et al., 2009). Physiotherapy in the forms 
of exercise and education has been shown to have positive effects on several 
aspects mentioned above (Busch, et al., 2007; Mannerkorpi, et al., 2000). In 
addition, exercise is commonly known to enhance general health, which 
facilitates coping with pain, fatigue and other symptoms in FM (Mannerkorpi 
& Gard, 2003). Contrary to many pharmacological treatments, physiotherapy 
generally gives no side effects, except for exercise induced pain in some 
patients. However, the pain most often decreases if the exercise is continued 
at an appropriate intensity for a few weeks (Hauser, et al., 2010).  
MFI general fatigue and MFI physical fatigue appear to be the most 
prominent fatigue dimensions regardless of condition and gender (d'Elia, et 
al., 2008; Rupp, et al., 2004; van Tubergen, et al., 2002). Treatment of fatigue 
would therefore benefit by being developed to improve these two fatigue 
dimensions. An improvement in general and physical fatigue could also have 
a positive impact on other dimensions of the MFI-20.  
In the present thesis, fatigue was shown to be associated with distress, and 
symptoms of depression were shown to be the most consistent explanatory 
variable of severe fatigue in the women FM, in line with previous findings 
(Nicassio, et al., 2002). Exercise has been shown to decrease symptoms of 
depression in female patients with FM (Sanudo et al., 2010), and it could be 
assumed to have a positive impact on their fatigue as well. Fatigue in FM and 
CWP might be aggravated as a side effect of some pharmacological 
treatment, which favors physiotherapy as the primary choice when planning 
treatment of fatigue in FM and CWP. 
In the present thesis, the effects of pool exercise combined with education 
were investigated in a randomized controlled study in women with FM and 
CWP. A pilot study was also conducted to explore the effects of pool 
exercise and resistance training in men with CWP. The results of the studies 
imply that exercise can improve some dimensions of fatigue. This is 
discussed further below. 
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6.3.1 Pool exercise and education in women with FM 
and CWP 
The randomized controlled trial in Study III showed that a 20-week 
programme combining pool exercise in temperate water with patient 
education improved health status measured with the FIQ in female patients 
with FM and CWP, which is consistent with previous studies of exercise and 
education (Burckhardt, Mannerkorpi, Hedenberg, & Bjelle, 1994; Cedraschi 
et al., 2004; Gowans, deHueck, Voss, & Richardson, 1999; King, Wessel, 
Bhambhani, Sholter, & Maksymowych, 2002; Mannerkorpi, et al., 2000; 
Rooks, et al., 2007).  The effect size of the FIQ total was considered to be 
small (0.31) in the ITT population, but it increased to 0.45 among the active 
participants (PP population). These results are comparable to effect sizes 
found in previous studies of patients with FM in primary health care (Garcia-
Campayo et al., 2008). 
In between-group analyses of active participants attending at least 60 % of 
the sessions (PP population), the exercise education group also improved in 
walking capacity measured with the 6MWT, as compared to the control 
group only participating in education. Compliance appears to be important 
for gaining positive effects on physical function. The change in 6MWT was 
smaller than expected, possibly due to the fairly high walking capacity in the 
patients at baseline. 
The improvement in the FIQ total in the exercise education group was 
supported by improvements in several other health related components in the 
ITT population. FIQ pain and activity related relaxation showed significant 
improvement in the exercise education group, as compared to the education 
only group, which might have contributed to the improved health status. The 
improvements are in line with previous findings of exercise in FM (Gowans 
et al., 2001). The pool exercise programme comprised one session a week for 
20 weeks. The recommended exercise frequency in FM is two times a week 
(Busch, et al., 2007; Hauser, et al., 2010), which might have given greater 
improvements in the exercise education group. 
Multiple dimensions of fatigue assessed with the MFI-20 were included as 
explorative outcomes in the present study. The exercise education group 
improved in the MFI reduced motivation as compared to the education only 
group. This result is in line with findings in a study investigating the effects 
of Nordic Walking in FM, in which the MFI reduced motivation was 
improved in the Nordic Walking group as compared to a control group with 
low-intensive walking (Mannerkorpi, Nordeman, Cider, & Jonsson, 2010).  
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exercise and resistance training in men with CWP. The results of the studies 
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discussed further below. 
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6.3.1 Pool exercise and education in women with FM 
and CWP 
The randomized controlled trial in Study III showed that a 20-week 
programme combining pool exercise in temperate water with patient 
education improved health status measured with the FIQ in female patients 
with FM and CWP, which is consistent with previous studies of exercise and 
education (Burckhardt, Mannerkorpi, Hedenberg, & Bjelle, 1994; Cedraschi 
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Bhambhani, Sholter, & Maksymowych, 2002; Mannerkorpi, et al., 2000; 
Rooks, et al., 2007).  The effect size of the FIQ total was considered to be 
small (0.31) in the ITT population, but it increased to 0.45 among the active 
participants (PP population). These results are comparable to effect sizes 
found in previous studies of patients with FM in primary health care (Garcia-
Campayo et al., 2008). 
In between-group analyses of active participants attending at least 60 % of 
the sessions (PP population), the exercise education group also improved in 
walking capacity measured with the 6MWT, as compared to the control 
group only participating in education. Compliance appears to be important 
for gaining positive effects on physical function. The change in 6MWT was 
smaller than expected, possibly due to the fairly high walking capacity in the 
patients at baseline. 
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only group, which might have contributed to the improved health status. The 
improvements are in line with previous findings of exercise in FM (Gowans 
et al., 2001). The pool exercise programme comprised one session a week for 
20 weeks. The recommended exercise frequency in FM is two times a week 
(Busch, et al., 2007; Hauser, et al., 2010), which might have given greater 
improvements in the exercise education group. 
Multiple dimensions of fatigue assessed with the MFI-20 were included as 
explorative outcomes in the present study. The exercise education group 
improved in the MFI reduced motivation as compared to the education only 
group. This result is in line with findings in a study investigating the effects 
of Nordic Walking in FM, in which the MFI reduced motivation was 
improved in the Nordic Walking group as compared to a control group with 
low-intensive walking (Mannerkorpi, Nordeman, Cider, & Jonsson, 2010).  
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Motivation has been shown to be a predictor of change in health related 
quality of life and working ability when patients with musculoskeletal pain 
participated in rehabilitation programme combining education, exercise, body 
awareness therapy and social activities (Grahn, Ekdahl, & Borgquist, 2000). 
Thus, the improvement in the MFI reduced motivation in the present study 
has probably interacted with the improvement in FIQ total and FIQ pain and 
the within-group improvements in health related quality of life among the 
exercisers. 
The other fatigue dimensions showed conflicting results, as some of them 
improved in the exercise-education group and others improved in the 
education group. Within-group analyses among the active participants (PP 
population) showed that MFI physical fatigue, MFI reduced activity and MFI 
reduced motivation improved in the exercise education group and MFI 
reduced activity improved in the education only group. The education 
programme included a physical contract aiming to motivate the patients to 
increase their level of physical activity, which could explain the within-group 
improvement in MFI reduced activity in both groups. 
The fatigue results in the present study indicated that the MFI-20 is sensitive 
to change in patients with FM and CWP. However, the minimal clinically 
important difference in fatigue dimensions of the MFI-20 needs to be studied 
further in order to establish the responsiveness of the instrument. 
Subgroup analyses were also made in the present thesis to investigate the 
influence of stress, pain, activity limitations and distress on changes in 
primary outcomes in female patients with FM and CWP. The patients were 
divided into two subgroups by using the median value for SCI-93 (<78>), 
FIQ pain (<70>) and the SF-36 physical functioning (<55>). The patients 
were also divided into two subgroups regarding distress, assessed with the 
subscale for depression in the HADS and using the cut-off point of possible 
depression (<8>) (Herrmann, 1997).  No significant heterogeneity was found 
in the subgroup analyses, but stress tended (p=0.07) to influence the change 
in the FIQ total, indicating that patients with lower scores for stress might 
improve more in health status as a consequence of the exercise than those 
with higher scores.  
Separate within-group analyses of patients rating lower levels of stress, pain 
and distress revealed a significant improvement in the FIQ total (p<0.05) 
among the exercisers, compared with the control group. No significant 
differences between the exercisers and the control group were found for the 
patients that rated high levels of stress, pain and distress. However, the 
Anna Ericsson 
69 
patients with more severe symptoms appeared to improve equally regardless 
of the type of intervention. 
 No significant heterogeneity was found for change in the 6MWT, which may 
be related to the small improvement in the exercise-education group 
discussed earlier. Subgroups based on symptom severity and physical 
impairments among patients with FM have been described in other studies 
(Calandre et al., 2011; Giesecke et al., 2003; Thieme, et al., 2007). To the 
best of our knowledge, the present study is the first to demonstrate subgroup 
differences in outcomes of exercise in patients with FM, suggesting that 
patients with milder symptoms gain the best effects of exercise. 
A limitation of the study was the choice of the control group that participated 
in education, a recommended treatment for patients with FM. The education 
programme consisted of six sessions, once a week, and was based on self-
efficacy principles requiring the active participation of the patients. The aim 
of the education was to introduce strategies to cope with fibromyalgia 
symptoms and to encourage regular physical activity. It would have been 
preferable for the control group not to have received any intervention at all. 
However, there were only few within-group improvements in the control 
group, which might owe to their long duration of pain. Many of the patients 
reported previous participation in patient education. 
 
6.3.2 Pool exercise and resistance training in men 
with FM and CWP 
The randomized trial in the pilot study showed that a 12-week supervised 
resistance training programme improved isometric force in right arm shoulder 
abduction and knee flexion in both legs in men with CWP when compared to 
a 12-week supervised pool exercise programme.  
The mean values of isometric force of the right arm shoulder abduction 
and knee flexion in both legs increased from baseline to 12-week 
examination by between 23 % and 30 % in the resistance training group. 
This is in line with studies of women with FM who increased their 
isometric knee extension force by 27-36 % after a 21-week period of 
resistance training (Hakkinen, et al., 2001; Valkeinen, et al., 2005). The 
increase in strength in the present study is also consistent with the 
expected improvement of resistance training in untrained and moderately 
trained healthy individuals (Kraemer, et al., 2002).  
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motivation, HADS anxiety and SF-36 physical component summary in the 
pool exercise group (p<0.05) and in right arm shoulder abduction, knee 
flexion in both legs and MFI general fatigue (p<0.05) (data not shown in the 
results section). 
The main limitation of the study was the small populations in the two 
exercise groups. There are also limitations when both groups in a randomized 
trial receive active treatments. Both treatments could have similar effects, 
complicating between-group analyses. A reference group was therefore 
recruited to study the natural course of CWP, which could confirm 
possible within-group changes in outcome variables. As the outcome 
variables did not change over time in the reference group, the within-
group improvements in the exercise groups can be assumed to have 
occurred by way of exercise. However, the reference group might be too 
small to make this conclusion certain. 
Despite the small sample size, significant differences were found in 
performance based tests among patients engaging in resistance exercise when 
compared to pool exercise, implying that men with CWP can improve muscle 
strength by resistance training.   
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There were no differences between the two exercise groups in change in 
fatigue at the 12-week examination. However, within-group analyses 
showed that MFI general fatigue decreased significantly over time in the 
resistance training group, and a tendency toward improvement in MFI 
general fatigue was also found in the pool exercise group (p=0.053). At 
the nine-month follow-up, the decrease in MFI general fatigue was 
statistically significant in both exercise groups as compared to baseline.  
The MFI reduced motivation was significantly improved over time in the 
pool exercise group, which is in line with the results of pool exercise in 
Study III in the present thesis as well as a previous study of aerobic 
exercise (Mannerkorpi, et al., 2010). Within-group improvements were 
also found in the pool exercise group for anxiety, which agrees with a 
previous study  (Jentoft, Kvalvik, & Mengshoel, 2001), and for the 
physical component summary of SF-36, with a mean increase of 4.3 (SD 
6.1), suggested to be a clinically relevant increase in chronic diseases 
(Angst, Aeschlimann, & Stucki, 2001; Coteur, Feagan, Keininger, & 
Kosinski, 2009). 
No change in pain intensity was found during the 12-week study period, 
but the lesser number of pain localizations in the resistance training group 
after 12 weeks of exercise indicates an improvement in the distribution of 
pain in this group. Both groups reported a lower number of pain 
localizations at the nine-month follow-up.  
There is a scarcity of studies investigating the effects of exercise in men with 
CWP, which was the reason for initiating the present pilot study. In women 
with FM and CWP, pool exercise has been shown to improve symptoms and 
physical function, while there is limited evidence of the effects of resistance 
training (Busch, et al., 2007). The two types of exercise were therefore 
chosen for the present study.  
The six men with FM constituted a small subgroup of CWP reporting more 
severe symptoms, especially in level of fatigue, stress and distress, and only 
four of them completed the 12-week examination.  To achieve a more 
homogenous sample, the FM patients were excluded from the main analyses. 
However, when the men with FM were included in the sample in tudy IV, the 
between-group analysis showed significant improvement in isometric force 
of right arm shoulder abduction (p=0.010) and right leg knee flexion 
(p=0.004) in the resistance training group as compared to the pool exercise 
group. When the men with FM were included in the within-group analyses in 
study IV, improvements were found in MFI physical fatigue, MFI reduced 
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7 CONCLUSION 
The subscales of the Swedish version of the MFI-20 were found to possess 
sufficient test-retest reliability and internal consistency in patients with FM 
and CWP. When the convergent construct validity was investigated, the 
associations between the subscales of the MFI-20 and the one-dimensional 
FIQ fatigue were fair to moderate in the female population and moderate to 
good in the male population, implying that the MFI-20 assesses different 
aspects of fatigue than the FIQ fatigue does in patients with FM. The MFI-20 
was found to be most useful in relation to aspects of employment and 
physical function in female patients with FM. 
Female patients with FM rated their fatigue higher than healthy women. 
General fatigue and physical fatigue appear to be the most prominent fatigue 
dimensions regardless of condition and gender.  
The randomized controlled trial in female patients with FM and CWP 
showed that patients participating in an exercise-education programme 
improved in overall health and pain as compared to patients only 
participating in education. Patients with milder symptoms of stress, distress 
and pain improved more in overall health by exercise combined with 
education than by education only. However, the patients with more severe 
symptoms appeared to improve equally regardless of the type of intervention. 
In the pilot study exploring the effects of exercise in men with CWP, a 
resistance training programme improved isometric strength as compared 
to a pool exercise programme. The results imply that men with CWP can 
increase muscle strength in a way similar to that in healthy individuals by 
resistance training. Resistance training could be recommended when the 
preference is to increase muscle strength, while pool exercise might be 
preferable when the subjective perception of health is of priority. 
However, larger patient samples are needed to be able to make these 
conclusions certain.  
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8 FUTURE PERSPECTIVES 
Fatigue is a symptom of substantial importance for patients with FM and 
CWP and needs to be considered when planning treatments for these patients. 
Treatments for fatigue should attempt to improve the dimensions of general 
fatigue and physical fatigue, since they appear to be severe in FM and CWP, 
as well as the dimension of reduced motivation, since motivation  has 
previously been shown to be a predictor of change in health related aspects 
(Grahn, et al., 2000)  and of importance for subjective impressions of 
improvement (Hudson, et al., 2009). It is also possible that treatment of 
distress might have a positive influence on fatigue as well in FM and CWP. 
Physiotherapy including exercise and education appears to contribute to 
improvements in fatigue. However, further studies of effects of physiotherapy 
on multidimensional fatigue are required in both female and male patients 
with FM and CWP.  
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